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Abstract

Since its characterization, the definitive shortcoming of the bacterial
luciferase (lux) bioluminescent reporter system has been its inability to express at
a functional level in the eukaryotic cellular background. While recent
developments have allowed for lux function in the lower eukaryote
Saccharomyces cerevisiae, they have not provided for autonomous function in
higher eukaryotes capable of serving as human biomedical proxies. Here it is
reported for the first time that, through a process of poly-bicistronic expression of
human codon-optimized lux genes, it is possible to autonomously produce a
bioluminescent signal directly from mammalian cells. The low background of the
bioluminescent signal, along with its characteristic lack of substrate amendment
required for bioluminescent production, makes a mammalian-based lux reporter
system ideal for real-time monitoring of cell culture or murine model systems.
The delectability of a lux-based system provides for a functionally equivalent
process to monitoring firefly luciferase-expressing cells under cell culture or
subcutaneous imaging conditions without the well-documented uncertainties
stemming from additional substrate introduction. However, the relatively blueshifted emission wavelength of the lux reporter system, along with its low
quantum yield, has been shown to reduce its effectiveness for use during deep
tissue imaging of animal subjects. Despite these disadvantages, it has been
demonstrated that a human cell line expressing the human codon-optimized lux
iv

genes can function as a biosensor for determination of human bioavailability of
toxic compounds and that, by regulating the production of the luxC and luxE
genes, the lux system can be employed as the first mammalian, real-time, fully
autonomous bioreporter. These cell lines provide unique and efficient models for
the detection and monitoring of human-relevant compounds of interest. The
limiting reagent for bioluminescent production in the mammalian cellular
background has been determined to be the cytosolic availability of the FMNH2
co-substrate and, in light of this evidence, directions for future optimization have
been characterized and evaluated in respect to their ability to increase
bioluminescent yield under these conditions.
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CHAPTER I
Introduction

Background And Research Objectives
Biosensors, with their small size, relative simplicity, rapidity of operation, and
continuous, real-time to near real-time monitoring capabilities, possess unique
characteristics conducive to the high throughput and remote-based monitoring
needs relevant to agricultural, environmental, pharmacological, and clinical
sensing. While the most popular biosensors have traditionally incorporated
enzymes or antibodies as their biorecognition elements, the development and
use of whole-cell biosensors (those housed entirely within a bacterial or
eukaryotic cell) has increased greatly in recent history because they possess
some interesting advantages over their enzymatic and immuno-dependent
counterparts. Primary among these advantages is the indication of bioavailability
— the effect and interactions the analyte has on a living system. As opposed to
analytical instruments that measure only the total concentration of a target
analyte in a sample, whole-cell biosensors that measure bioavailability indicate
that the analyte can be assimilated by or directly affect a living organism, thereby
exposing possible toxic interactions. Another advantage of whole-cell
bioreporters is that they can be designed to produce signal in a constitutive
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manner, regardless of the presence of a target analyte. This makes them
valuable tools for localization and monitoring of cellular activities under in vivo, in
vitro, or in situ conditions in ways not possible with traditional analytical
equipment.
One important consequence of bioreporter-based interrogation has been the
recent rise of whole animal bioluminescent imaging (BLI). This technique is
progressively becoming more widely applied by investigators from diverse
backgrounds because of its low cost, high throughput, and relative ease of
operation in visualizing a wide variety of in vivo cellular events (Baker 2010).
The ability to visualize cellular processes or other biological interactions without
the requirement for animal subject sacrifice allows for repeated imaging and
releases investigators from the constraints of considering their process of interest
on a “frame-by-frame” basis using labeled slides. In addition, the ability to
continually monitor a single individual reduces the amount of measured variation
and can reduce error, leading to higher resolution and less data loss. With
continuing advances in the hardware and software required for performing these
experiments, it is also becoming easier for researchers with little background in
molecular imaging to obtain useful and detailed publication-ready images.
The mainstays of BLI are the light generating luciferase enzymes such as
firefly luciferase, Renilla luciferase, Gaussia luciferase, Metridia luciferase,
Vargula luciferase, or bacterial luciferase (Thompson, Nagata et al. 1989; Wood,
Lam et al. 1989; Lorenz, McCann et al. 1991; Meighen 1991; Verhaegen and
Christopoulos 2002; Markova, Golz et al. 2004). These bioluminescent proteins
2

are preferred over their fluorescent counterparts because the lack of endogenous
bioluminescent reactions in mammalian tissue allows for near background-free
imaging conditions whereas the prevalence of fluorescently active compounds in
these tissues can interfere with target resolution upon exposure to the
fluorescent excitation wavelengths required for the generation of signal output.
Of these luciferase-based reporters, only those based on the bacterial luciferase
gene cassette have the potential for development into a fully autonomous
reporter system, negating the need for addition of a potentially influential
substrate that could create undo error during the data acquisition process. The
development of the bacterial luciferase gene cassette into a functional
mammalian-based bioreporter has been the focus of this work and has been
performed under the following experimental hypotheses:

•

Hypothesis 1: Through a process of poly-bicistronic expression of
Photorhabdus luminescence genes codon-optimized for expression in
mammalian cells it will be possible to autonomously produce a
bioluminescent signal in the human HEK293 cell line.

•

Hypothesis 2: Bioluminescent expression driven by codon-optimized
bacterial luciferase genes will allow improved temporal detection of signal
compared to bioluminescent signal from firefly luciferase and fluorescent
signal from green fluorescent protein in HEK293 cell culture and nude
mouse models.
3

•

Hypothesis 3: By regulating the expression of the luxC and luxE genes
from the bacterial luciferase gene cassette it will be possible to construct a
bioluminescent reporter capable of responding to changes in target
analyte presence autonomously and in a near real-time manner.

•

Hypothesis 4: HEK293 cells constitutively expressing bioluminescence
through expression of the codon-optimized bacterial luciferase genes will
be capable of acting as real-time biosensors to determine the mammalian
bioavailability of toxic chemicals.

Literature Review
Bacterial luciferase
Bioluminescent bacteria are the most abundant and widely distributed of the
light emitting organisms on Earth and can be found in both aquatic (freshwater
and marine) and terrestrial environments. Despite the diverse nature of bacterial
bioluminescence, the majority of these organisms are classified into three
genera: Vibrio, Photobacterium, and Photorhabdus (Xenorhabdus). These
bacteria often exist as symbiotes of other organisms, although some can be freeliving in aquatic environments as well. Of the known genera of bioluminescent

4

bacteria, only those from the genus Photorhabdus have been discovered in
terrestrial habitats (Meighen 1991).
Today it is well known that the bacterial bioluminescence reaction is the result
of two proteins, LuxA and LuxB, that work together to produce light from the
oxidation of a long chain fatty aldehyde in the presence of reduced riboflavin
phosphate (FMNH2) and oxygen, while the remaining proteins in the lux operon,
LuxC, LuxD, and LuxE, function to regenerate the aldehyde substrate required
for this reaction (Figure 1A). However, this was not always so evident. The study
of bacterial bioluminescence is rooted in the lessons of general bioluminescence.
The idea that oxygen was a required substrate for bioluminescent reactions
stems from Robert Boyle’s early experiments in the mid 1600’s showing that
removal of oxygen caused the cessation of light from what was either luminescent
bacteria or fungi (Boyle 1666). In the late 1880’s when it was discovered from
work in beetles that bioluminescence required a luciferase and a luciferin for
function, this knowledge was applied to the bacterial system as well (McElroy
and Strehler 1954).
In 1942 Doudoroff was one of the first to observe and report on the
metabolism of bioluminescent bacteria and found that all were able to tolerate
oxygen, aiding in the confirmation that oxygen was required for light production
(Doudoroff 1942). Although the first published report of a bioluminescent reaction
occurring outside of a bacterium occurred in 1920, it could not be reproduced
reliably until 1953 when McElroy and colleagues (McElroy, Hastings et al. 1953)

5

A

B

Figure 1. Bioluminescent reaction catalyzed by the bacterial luciferase genes.
A) The luciferase is formed from a heterodimer of the luxA and luxB gene products. The aliphatic
aldehyde is supplied and regenerated by the products of the luxC, luxD, and luxE genes. The required
oxygen and reduced riboflavin phosphate substrates are scavenged from endogenous metabolic
processes, however, the flavin reductase gene (frp) aids in reduced flavin turnover rates in some
species. B) The production of light, catalyzed by the products of the luxA and luxB genes, results from
the decay of a high energy intermediate (R1 = C13H27). Originally published in (Close, Ripp et al.
2009), reprinted with permission.
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were able to consistently produce light from autolysates of Achromobacter
fischeri cultures upon addition of FMN. At this time they also reported the
requirement for a luciferin compound of unknown structure. This was the first
indication that FMN was required for bacterial bioluminescence. It was not until
the next year that the structure of the luciferin was confirmed to be a long chain
fatty aldehyde (Strehler, Harvey et al. 1954).
This completed the list of required substrates, and an understanding was
established that bacterial luciferase catalyzes the production of light through
oxidation of a long chain fatty aldehyde in the presence of oxygen and reduced
riboflavin phosphate. The genes encoding the bacterial luciferase were first
cloned and expressed in E. coli in 1982 (Belas, Mileham et al. 1982), while the
full bacterial luciferase cassette was cloned and expressed the next year
(Engebrecht, Nealson et al. 1983). In the mid 1990’s the first crystal structure of
the bacterial luciferase heterodimer was determined (Fisher, Raushel et al.
1995), providing the first glimpse at the proteins that had captured researchers
imaginations for hundreds of years.
When the bacterial luciferase enzyme is supplied with oxygen, FMNH2, and a
long chain aliphatic aldehyde, it is able to produce light primarily at a wavelength
of 490 nm. There is a secondary emission peak at 590 nm, however, this is only
detectable using highly sensitive Raman scattering (Thouand, Daniel et al. 2003).
The natural aldehyde for this reaction is believed to be tetradecanal, however,
the enzyme is capable of functioning with alternative aldehydes as substrates
(Meighen 1991). The first step in the generation of light from these substrates is
7

the binding of FMNH2 by the luciferase enzyme, and until recently its active site
on the enzyme was not known. It has recently been confirmed, however, that
FMNH2 binds on the α subunit in a large valley on the C-terminal end of the βbarrel structure (Campbell, Weichsel et al. 2009).
In order for the reaction to proceed, the luciferase must undergo a
conformational change following FMNH2 attachment. This movement is primarily
expressed in a short section of residues known as the protease labile region—a
section of 29 amino acids residing on a disordered region of the α subunit joining
α-helix α7a to β-strand β7a. The majority of residues in this sequence are unique
to the α subunit and have long been implicated in the bioluminescent mechanism
(Baldwin, Christopher et al. 1995). Following attachment of FMNH2, this region
becomes more ordered and is stabilized by an intersubunit interaction between
Phe272 of the α subunit and Tyr115 of the β subunit. This conformational change
has been theorized to stabilize the α subunit in a conformation favorable for the
luminescent reaction to occur (Campbell, Weichsel et al. 2009).
NMR studies have suggested that FMNH2 binds to the enzyme in its anionic
state (FMNH-) (Vervoort, Muller et al. 1986). With the flavin bound to the enzyme,
molecular oxygen then binds to the C4 atom to form an intermediate 4αhydroperoxy-5-hydroflavin (Nemtseva and Kudryasheva 2007). It is important to
note that this critical C4 atom was determined to be in close proximity to a reactive
thiol from the side chain of Cys106 on the α subunit (Campbell, Weichsel et al.
2009), a residue that has long been hypothesized to play a role in the
8

bioluminescent reaction, but recently has been proven to be non-reactive through
mutational analysis (Baldwin, Chen et al. 1987).
It has been shown, however, that C4 is the central atom for the luciferase
reaction and, following establishment of the hydroperoxide there, it is capable of
interaction with the aldehyde substrate via its oxygen molecule to form a
peroxyhemiacetal group. This complex then undergoes a transformation (through
an unknown intermediate or series of intermediates) to an excited state generally
accepted to be a luciferase-bound 4α-hydroxy-5-hydroflavin mononucleotide. As
this complex decays, it yields oxidized FMN, a corresponding aliphatic acid, and
light (Figure 1B) (Nemtseva and Kudryasheva 2007). There have classically
been many theories proposed to explain the exact process required for light
emission (Hastings and Nealson 1977), and these continue to expand today as
technology for detecting the intermediate complexes has improved. For a review
of the proposed mechanism and their strengths and weaknesses, the reader is
directed to Nemtseva and Kudryasheva (Nemtseva and Kudryasheva 2007).
While the bacterial luciferase protein is all that is required to generate light in
the presence of its required substrates, it is often beneficial for investigators to
express other genes from the operon in order to supply the luciferase with the
substrates required for its autonomous function. To accomplish this, it is
necessary to co-express the luxC, luxD, and luxE genes. The products of these
genes assemble into a multi-enzyme complex and are responsible for
biosynthesis of myristyl aldehyde using components already present in the cell,
thus negating the requirement to supply an aldehyde substrate exogenously.
9

The luxD gene encodes a transferase protein and is the first to act in the
aldehyde biosynthesis pathway. It is responsible for the transfer of an activated
fatty acyl group to water, forming a fatty acid. During the course of this reaction
the enzyme itself becomes acylated. The newly formed fatty acid is next passed
off to the luxC gene product, which activates the acid by attaching AMP from a
molecule of ATP, thereby creating a fatty acyl-AMP that remains tightly bound to
the enzyme. The fatty acyl-AMP is then transferred to the luxE gene product via
transfer of the acyl group. This protein acts as a reductase and catalyzes the
reduction of the fatty acyl-AMP to aldehyde using NADPH to supply the required
reducing power (Meighen 1991). This allows for the in vivo generation of the
aldehyde substrate. Because the organism naturally supplies the remaining
FMNH2 and oxygen substrates, the co-expression of these genes represents the
minimum requirement for allowing the lux system to operate in a fully
autonomous fashion.
lux biosensors and applications

Prior to the demonstration of autonomous lux function in the mammalian
cellular environment detailed here, the use of lux as a reporter has been limited
solely to use in prokaryotic organisms and the lower eukaryote Saccharomyces
cerevisiae. However, the experimental designs that have been employed are
similar to those used when the system is expressed in a mammalian cellular
host. The most basic bacterial luciferase associated reporter assays are those
based on determining the presence or level of bioavailability of toxic compounds.
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Taking advantage of the autonomous nature of the lux operon, bioreporters have
been engineered to constitutively express light under environmental conditions.
Upon exposure of the bioluminescent reporter to a toxic compound, it undergoes
a metabolic slowdown or death, causing a decrease in the total bioluminescent
signal (Kelly, Lajoie et al. 1999). These assays, such as the commonly used
Microtox assay (Johnson 2005), can be used to indicate that a toxic compound is
present but they do not necessarily identify what that compound is. To permit
identification of the toxicant, multiple bioreporter types are engineered to
specifically respond only to certain target compounds or analytes of interest. The
ability of cells to regulate transcription in response to specific compounds is
taken advantage of in these sensing strategies to create fusions of target specific
gene sequences with the bioluminescent lux genes. Thus, when exposed to a
target compound, these bioreporter cells will emit bioluminescent light signals
that are either dependent on the addition of a decanal substrate (if only the luxAB
genes are used) or fully autonomously (if the luxCDABE genes are used
together) (Ripp, DiClaudio et al. 2009). A distinct advantage of the fully
autonomous luxCDABE-based bioreporters is the ability to report target analyte
presence continuously and in a real-time or near real-time format. Historically,
one problem associated with real-time monitoring has been the slow turnover
time of the bioluminescent reaction. Coupled with the long life of the luciferase
heterodimer, this has made it difficult to resolve reporter function over short
periods of time. In order to compensate for this, it has been demonstrated that
inclusion of a protease tag can shorten the lifespan of the luciferase proteins and
11

increase the temporal resolution of lux-based reporters (Allen, Wilgus et al.
2007). In addition to the traditional chemical targets, lux-based reporter systems
have also been designed to detect biological targets such as food and
waterborne pathogens. In these systems, a bacteriophage, or bacterial virus, is
used as a carrier of the lux genes and its ability to infect only certain bacterial
hosts is exploited as a means towards delivering bioluminescence to a target
bacterium (Ripp 2009).
An important advantage stemming from the autonomous nature of the
bacterial luminescence cassette is that, since it does not require substrate
addition for expression, it can be used remotely if coupled to a proper detection
device. This allows for the monitoring of compounds of interest that may be
inaccessible to the researcher under normal conditions because of logistical or
safety concerns (Nivens, McKnight et al. 2004).
As a truly autonomous expression system, lux interfaces extremely well with
signal transducers and has seen widespread use in biosensor applications. Fiber
optic cables represent one of the easiest interfaces, with the bioreporters
immobilized at one end of the cable and the other end terminating at a
photomultiplier tube (PMT) or other luminometer-type device. The cable can then
be inserted into liquid, solid, or gaseous samples to remotely monitor for target
analytes such as heavy metals, polycyclic aromatic hydrocarbons (PAHs), or for a
general assessment of sample toxicity (Heitzer, Malachowsky et al. 1994; Polyak,
Bassis et al. 2001; Leth, Maltoni et al. 2002; Chang, Lee et al. 2004; Ivask, Green et
al. 2007). Multi-fiber optical devices immobilized with differently target sensitive
12

bioreporters have also been developed and field tested for multiplexed
monitoring (Hakkila, Green et al. 2004). In this same vein, but perhaps more user
friendly, is the Lumisens 2 instrument developed by Horry (Horry, Charrier et al.
2007), a device where bacteria acting as lux-based reporters are immobilized on
a disposable card rather than the fiber optic cable itself. A fiber optic cable then
scans each individually immobilized bioreporter to monitor for bioluminescence
output in a flow-through format. Similar flow-through samplers have been
constructed using bioreactors containing growing cultures of the bioreporter into
which bare fiber optic cables are inserted. Upon exposure to a target analyte or
toxic intermediate, the bioreporter culture yields increased (or diminished)
bioluminescence that is detectable via the integrated fiber optics. Continuous, online water toxicity monitoring has been demonstrated using small-scale (1–2 mL)
bioreactors and larger commercially available systems such as the TOXcontrol
sensor that can be plumbed into pre-existing water lines (Lee and Gu 2005).
Fiber optics have also been used to monitor lux-expressing bacteria in their
natural environment to non-invasively assess metabolic and physiological
responses to ecosystem perturbations, for example, the addition of a
contaminant (Dorn, Mahal et al. 2004).
Although functional, the requisite linkage of the fiber optic cable to a PMT or
other light gathering device necessitates size and power constraints that are not
conducive to miniaturization. To address this, several groups have developed
different variations of chip-based microluminometers that can directly interface
with the bioreporter organisms. This negates the need for a fiber optic cable to
13

channel the signal to a transducer and instead forms an all-inclusive bioreporteron-a-chip biosensor. This technology was first demonstrated with the
bioluminescent bioreporter integrated circuit (BBIC) that consisted of a small (1.5
× 1.5 mm), low-power (3 mW) CMOS microluminometer for light gathering and a
transmitter for remote data transmission (Vijayaraghavan, Islam et al. 2007).
Polymer encapsulants attach the bioreporters directly on to the BBIC surface or
the BBIC can be interfaced with bioreporter inoculated flow-cells or bioreactors.
For field monitoring, the BBIC has been incorporated into a handheld wand that
operates off of an internal lithium watch battery (Figure 2) (Ripp, Daumer et al.
2003).
As a photodetector add on, MOEMS (Micro-Opto-Electro-Mechanical-System)
can increase detection limits by minimizing system noise using an integrated
heterodyne optical system (IHOS) technique that modulates bioreporter
bioluminescence prior to photoconversion (Elman, Ben-Yoav et al. 2008). A
MOEMS modulator/solid state photodetector interface has been tested with a lux
bioreporter and a minimum detectable signal of 109 photons/sec/cm2 was
demonstrated. To accommodate multiplexed, multi-analyte sensing on a single
chip, Eltoukhy et al. (Eltoukhy, Salama et al. 2006) designed a 128 channel array
CMOS microluminometer capable of holding and individually sensing multiple
bioreporters simultaneously, thus enabling high density fingerprinting of sample
chemical makeup using any of the many differently analyte-specific bioreporters

14

Bioreporter
interface

Figure 2. Example of a CMOS microluminometer
transducer in a hand-held biosensor format.
Bioreporter cells engineered to emit bioluminescent
light signals are directly interfaced to the transducer
element to form a compact and remotely operable
biosensor. Originally published in (Close, Ripp et al.
2009), reprinted with permission.
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available, all within a single lab-on-a-chip platform. Avalanche photodiodes
(APDs) may also be of utility to bioreporter sensing as they can be designed for
photon counting, much like a photomultiplier tube, but in a miniaturized
standalone design (Yotter and Wilson 2003). APDs currently represent the most
sensitive solid-state devices available and can achieve quantum efficiencies
greater than 90%. However, they require higher operating voltages, generate
excessive background noise that may mask low level signals generated from
bioreporter cells, and their complex circuitry translates into high cost. Despite
these disadvantages, Daniel et al. (Daniel, Almog et al. 2008) have preliminarily
tested an APD in conjunction with a stress responsive lux bioluminescent
bioreporter within a 10 µL sample chamber and demonstrated sufficient
sensitivity at low part-per-million concentrations of a nalidixic acid inducer. This
group has also recently developed an integrating sphere device capable of
measuring absolute photon numbers emanating from bioluminescent cells,
which, although too complex and fragile to serve as a biosensor, should find
important utility in shaping factors fundamental to biosensor engineering such as
quantum yield and minimum signal detection parameters (Daniel, Almog et al.
2009).
While many of these examples have utilized bacteria as the host for the lux
system, they provide valuable insights into how human cells expressing
mammalian-adapted lux genes can be employed to serve as biosensors under
real-world conditions. There are, of course, logistical concerns surrounding the
growth and maintenance of human cell lines as compared to bacterial cells, but
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advances in cell culture techniques and cell encapsulation technology will one
day allow for duplication of many of these experimental designs using human
cells as the reporter organism. This would allow the determination of human
bioavailability under environmental conditions and provide valuable information
on metabolism and uptake of the above mentioned targets in way that has not
previously been possible.
Firefly luciferase
Firefly luciferase (Luc) is the best studied of a large number of luminescent
proteins to be discovered in insects. The insects represent a large related group
of bioluminescent organisms, with over 2,500 species reported to be capable of
generating light (Viviani 2002). While the vast majority of these luminescent
reactions remain unstudied, the exception is in the order Coleoptera (beetles)
where systems have been characterized for the chick beetles, railroad worms,
and fireflies (predominantly Photinus pyralis) (Fraga 2008). Fireflies produce light
in an organ called a lantern, using the rapid introduction of oxygen as a trigger for
luminescence in order to attract mates as well as deter potential predators (Lewis
and Cratsley 2008).
The first studies of the mechanism behind insect luminescence were carried
out in the late 1800’s by Raphael Dubois using ground up abdomens from the
Elanteridae beetle. It was from these experiments that Dubois first proposed the
existence of a system employing a luciferase and a luciferin for the production of
light. The next advance came from Newton Harvey, who reported on the
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specificity of luciferase/luciferin interactions and confirmed the requirement for
molecular oxygen (Fraga 2008). In the mid 1900’s William McElroy began what
was to be a long and successful career working with firefly luciferase by
discovering the requirement that ATP be involved in the luminescent reaction
(McElroy 1947). Based in part on these findings, his group soon proposed that
the bioluminescent reaction occurred via a two step process (Hastings, McElroy
et al. 1953) and was the first to determine the structure of the firefly luciferin as 2(4-hydroxybenzothiazol-2-yl)-2-thiazoline acid (White, Field et al. 1961) —
commonly abbreviated as D-luciferin in the literature. In the late 1960’s and
1970’s the mechanism underlying the luminescent reaction was reported (White,
Rapaport et al. 1969; McCapra 1976), as was the confirmation of the
intermediate products of this proposed reaction (Fraga 2008). The mechanism
was finally secured in 1980 when oxyluciferin was isolated as a purified product
of the D-luciferin luminescence reaction (White, Steinmetz et al. 1980). The latest
advance in the understanding of firefly luciferase came in 1996 when Conti
(Conti, Franks et al. 1996) published the crystal structure of the luciferase at a
resolution of 2.0 Å. This opened the door for targeted mutagenesis investigations
and gave researchers the first look at the structure of this reporter protein.
The Luc protein catalyzes the oxidation of the reduced luciferin (D-luciferin) in
the presence of ATP-Mg2+ and oxygen to generate CO2, AMP, PPi, oxyluciferin,
and yellow-green light at a wavelength of 562 nm (Figure 3). It is important to
note that D-luciferin is a chiral molecule, and while both the D and L forms can
bind to Luc and participate in adenylation reactions, only the D form is capable of
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Figure 3. Bioluminescent reaction catalyzed by firefly luciferase.
The luciferase protein holds the reduced luciferin to allow for adenylation (a). This process is
followed by a deprotonation reaction that leads to the formation of a carbanion (b) and attack by
oxygen (c), driving the formation of a cyclic intermediate (d). As this intermediate decays, carbon
dioxide is released, forming the excited state luciferin in either the keto (e) or enolate (f) form.
Originally published in (Branchini, Magyar et al. 1998), reprinted with permission.
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continuing on in the reaction to generate light (Fraga 2008). This reaction was
originally reported to occur with a quantum yield of 0.88 (Seliger and McElroy
1960), but has since been shown to actually achieve a quantum yield closer to
only 0.41 (Ando, Niwa et al. 2007). Because of the high quantum yield, the
reaction is well suited to use as a reporter with as few as 10−19 mol of luciferase
(2.4 × 105 molecules) able to produce a light signal capable of being detected
(Gould and Subramani 1988).
It has been known since the early 1950’s that the chemical reaction underlying
firefly luminescence is a two-step process that first requires adenylation of Dluciferin followed by oxidation and the production of light (Hastings, McElroy et al.
1953). Prior to the initiation of the reaction, the Luc protein must first bind to Dluciferin. However, at this time it is not yet capable of undergoing oxidation or
producing light. The first step in the generation of light is the adenylation of the
bound D-luciferin with the release of pyrophosphate (Ugarova 1989). The
function of this adenylation is to increase the acidity of the C4 proton of the
thiazoline ring on D-luciferin. This allows for removal of a proton from C4 causing
formation of a carbanion (McCapra, Chang et al. 1968). This carbanion is then
attacked by oxygen, displacing AMP and driving the formation of a cyclic
peroxide with an associated carbonyl group (a dioxetanone ring). As the bonds
supporting this structure collapse, it becomes decarboxylated, releasing CO2 and
forming an electronically excited state of oxyluciferin in either the enol or keto
form (Ugarova 1989).
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The kinetics of this reaction can be altered by varying the concentration of the
substrates, with low concentrations (in the nM range) showing steady light
production and high concentrations (µM range) producing a bright flash followed
by decay to 5 – 10% of the maximum (DeLuca, Wannlund et al. 1979). There are
multiple possible inhibitory compounds that could be responsible for the kinetic
profile generated under high substrate concentrations. It has previously been
shown that, even though oxyluciferin is a natural product of the luciferase
reaction, it is capable of remaining bound as an inhibitor to enzymatic turnover
(Denburg, Lee et al. 1969). The same was found to be true of another potential
byproduct, L-AMP, which can account for up to 16% of the product formed during
the luminescent reaction (Fontes, Ortiz et al. 1998). This may, in part, explain
how the addition of CoA to the luminescent reaction can result in improved
performance. When CoA is added during the initial steps of the reaction, it
prevents the fast signal decay normally observed, and when it is added following
this decay it can promote re-initiation of the flash kinetics. This can be attributed
to CoA’s interaction with L-AMP to form L-CoA, resulting in turnover of the Luc
enzyme and reoccurrence of the luminescent reaction (Airth, Rhodes et al.
1958).
Insects, and specifically beetles, that produce luminescence are quite diverse
in the colors they are capable of producing. It was originally believed that the
colors were the result of divergent luciferase structures, however, the sequences
of four luciferase genes from Pyrophorus plagiophthalamus with four different
emission spectra were sequenced and it was found that they shared up to 99%
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amino acid identity (Wood, Lam et al. 1989). There are currently three
mechanisms that have been proposed to explain the multiple bioluminescent
colorations: the active site polarity hypothesis (DeLuca 1969), the
tautomerization hypothesis (White and Branchini 1975), and the geometry
hypothesis (McCapra, Gilfoyle et al. 1994).
The active site polarity hypothesis is based on the idea that the wavelength of
light produced is related to the microenvironment surrounding the luminescent
protein during the reaction. In non-polar solvents the spectrum is shifted towards
blue and in polar solvents it is more red-shifted. It is questionable, however, if
polarity fluctuations can account for large scale changes like those that have
been observed in P. plagiophthalamus. The tautomerization hypothesis states
that the wavelength of light produced is dependent on whether either the enol or
keto form of the luciferin is formed during the course of the reaction. A recent
study has reported that by altering the substrate of the reaction the keto form of
the luciferin can produce either red or green light, making this hypothesis unlikely
as well (Branchini, Murtiashaw et al. 2002). Finally, the geometry hypothesis
suggests that the geometry of the excited state oxyluciferin is responsible for
determining the emission wavelength. In a 90° conformation it would achieve its
lowest energy state and red light would be produced, whereas in the planar
conformation it would be in its highest energy state and green light would be
produced. Intermediate colors would be the result of geometries between these
two extremes (Viviani 2002).
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Luc biosensors and applications

Firefly luciferase makes an excellent reporter for the reasons previously
discussed, however, its major hurdle for use has always been the inability for
detection in real-time due to the requirement for addition of a separate luciferin.
Despite this drawback, Luc has become the most popular reporter protein for
bioluminescent imaging because its bright signal allows for detection even at low
reporter population sizes. For example, Kim and colleagues have demonstrated
this advantage with the newest generation of these reporters designed for tumor
detection. The investigators were able to inject codon-optimized Luc containing
4T1 mouse mammary tumor cells subcutaneously and then image single
bioluminescent cells at a background ratio of 6:1 (Kim, Urban et al. 2010). This
experiment effectively demonstrates how a Luc-based reporter can be used to
continuously monitor cancer development from a single cell all the way to
complete tumor formation.
Some researchers have also managed to take advantage of the dependence
of the Luc system on the presence of its D-luciferin substrate to produce a
detectable signal. Through bioluminescence resonance energy transfer (BRET)
Angers et. al. was able to demonstrate the presence of G-protein coupled
receptor dimers on the surface of living cells. By tagging a subset of β2adrenergic receptor proteins with Luc and a subset with the red-shifted variant of
green fluorescent protein, YFP, it was possible to detect both a luminescent and
fluorescent signal in cells expressing both variants, but no fluorescent signal in
cells expressing only YFP since no fluorescent excitation signal was used
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(Angers, Salahpour et al. 2000). This was made possible because the
bioluminescent signal from Luc required to stimulate the fluorescent signal of
YFP was not constantly produced, allowing the researchers to detect YFP
independently from the Luc signal, and then subsequently visualizing where Luc
was expressed either in tandem or independently of the associated YFP protein.
Due to its persistence as the most widely used bioluminescent protein in the
optical imaging field, there have been myriad other uses of the Luc protein in
both cell culture and small animal imaging applications. Multiple reviews have
been published detailing the standard and novel implementations of this versatile
protein, but suffice it to say that it is not without reason that Luc is consistently
employed by a wide variety of researchers. The intense bioluminescent signal
allows for facile detection using short integration times and simultaneously allows
for detection under conditions of heave photo-scattering and absorption. The
examples used here provide only brief highlights as to the functional sensitivity
and range of use afforded by the Luc reporter system.
Green fluorescent protein
Green fluorescent protein (GFP) was first discovered during investigation into
the related chemiluminescent protein aequorin from the jellyfish Aequorea
Victoria (Shimomura, Johnson et al. 1962). Since that time it has been realized
that the Aequorea derived GFP is just one of a larger family of homologous
fluorescent proteins capable of producing light in a variety of colors due to
alterations in the covalent structure of their chromophores or differences in the
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surrounding non-covalent environment (Giepmans, Adams et al. 2006). Despite
its early discovery, the use of GFP as a research tool did not begin until after it
was successfully cloned almost thirty years later (Prasher, Eckenrode et al.
1992). However, soon after the cDNA was available, its function was validated in
both prokaryotic and eukaryotic organisms by Chalfie (Chalfie, Tu et al. 1994),
and since that time it has been used in numerous applications including
localization studies, protein expression monitoring, as a reporter gene, as a
viability marker, to detect the onset of apoptosis, and many others (reviewed in
(Zimmer 2002)).
GFP has become a favored tool for molecular studies because it is
autofluorescent and does not require the addition of any cofactors to properly
function in exogenous systems (Naylor 1999), although it does require activation
by an excitation light source before its signal can be measured. It has been
shown to be resistant to heat, alkaline pH fluctuations, chaotropic salts, organic
solvents, and many proteases (Ehrmann, Scheyhing et al. 2001), and its
expression in exogenous environments is primarily non-toxic (Zimmer 2002) with
a few proven exceptions (Hanazono, Yu et al. 1997; Liu, Jan et al. 1999) that may
be due to production of hydrogen peroxide as a by-product of synthesis (Tsien 1998).
However, the slow posttranslational chromophore formation and oxygen
requirement of GFP, along with potential difficulty in distinguishing its signature
from background fluorescence (Zimmer 2002), can be problematic, especially in
aerobic organisms. Because of this, alternate fluorescent proteins such as those
based on flavin mononucleotide are often used when developing reporters for
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anaerobic organisms (Drepper, Eggert et al. 2007). Time, though, has proven
that the benefits outweigh the challenges for most investigators, and GFP has
taken its place as one of the most popular tools currently available for cellular
and molecular signaling research.
Wild-type GFP protein is able to absorb light at two different wavelengths. A
minor peak occurs at 475 nm with the major peak at 397 nm (Figure 4).
Regardless of which excitation wavelength is used, emission occurs only at 504
nm (Patterson, Knobel et al. 1997). The different absorption peaks have been
attributed to varying protonation states of the fluorophore, with the neutral state
corresponding to the major absorption peak at 397 nm and the anionic form
contributing to the minor peak at 475 nm (Niwa, Inouye et al. 1996). The large
shift between the major absorption peak at 397 nm and the emission at 504 nm
can be attributed to an excited state proton transfer from the side chain of the
Tyr66 residue of the fluorophore (Chattoraj, King et al. 1996) to the carboxylate
oxygen of Glu222 (Zimmer 2002).
Based on this interconversion of the fluorophore, a three state model of
photoisomerization has been put forward to explain the chemical basis for shifts
in absorption. This model states that excitation of the neutral state fluorophore can
cause conversion to the anionic form via an intermediate (Chattoraj, King et al.
1996). The intermediate is structurally similar to the neutral form of the
fluorophore, but has become deprotonated at the phenol group of Tyr66 (Zimmer
2002). Excitation of the anionic form is capable of directly emitting fluorescence,
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Figure 4. The dual absorption peaks in the GFP spectra are the result of different
charge states in the GFP chromophore.
The neutral state (left) is responsible for the major peak at 397 nm while the anionic form
(right) is responsible for the minor peak at 475 nm. Regardless of the chromophore charge
state, emission occurs at 504 nm. Adapted from Scholarpedia.org.
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while the neutral state must necessarily convert into an excited form of this
intermediate prior to emission (Jung, Wiehler et al. 2005). While it is possible for
the neutral form to convert to the anionic form following excitation, this is not the
most favorable reaction. The majority of excited, neutral fluorophores will convert
briefly to the intermediate state, where fluorescence will occur, followed by
reversion back to the neutral state (Chattoraj, King et al. 1996). Interconversion
between the neutral and anionic states is possible, but requires both proton
transfer and conformational change to occur (Zimmer 2002). Similarly, the
majority of anionic fluorophores will revert to the ground state following
fluorescent emission, but could instead undergo a conformational change to the
intermediate state and then continue on to adopt a neutral charge state
(Chattoraj, King et al. 1996).
In a wild-type population, GFP contains a 6:1 ratio of neutral to anionic
fluorophores (Tsien 1998), explaining why the major absorption peak is found at
397 nm. However, upon extended ultraviolet (UV) illumination this peak will begin
to decrease and the minor peak will increase (Cubitt, Heim et al. 1995). This
behavior corresponds to the photoisomerization of the neutral fluorophore form
responsible for the major absorption peak being converted into the anionic form
as discussed above. While the photoisomerization characteristics of GFP can
prove problematic for quantification, they do allow for the study of protein
movement by excitation with intense UV light at 397 nm followed by excitation at
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475 nm in order to track the movement of the photoisomerized fluorophores
(Yokoe and Meyer 1996).
Following the discovery of GFP, it was quickly proven that amino acid
substitutions were capable of altering its fluorescent characteristics. Since that
time, versions of GFP have been developed that fold more efficiently at higher
temperatures (Crameri, Whitehorn et al. 1996), avoid dimerization at high
concentration (Zacharias, Violin et al. 2002), or fluoresce in the blue (Heim,
Prasher et al. 1994), cyan (Heim and Tsien 1996), or yellow (Ormo, Cubitt et al.
1996) wavelengths. Homologs have since been discovered that fluoresce in the
red range as well (Matz, Fradkov et al. 1999). The history and development of
these variants is outside the scope of this review, but an excellent classification
has been made by Tsien (Tsien 1998) and abridged by Zimmer (Zimmer 2002)
dividing the known variants into seven classes based on spectral characteristics.
When applied in concert, these variants of the GFP protein have given
researchers the ability to use multiple GFP-based reporters in the same
environment at the same time, improving the usefulness and range of this
already dynamic protein.
GFP biosensors and applications

Since it was first demonstrated that GFP could be expressed in E. coli
(Chalfie, Tu et al. 1994), it has been used in countless experiments in organisms
ranging from bacteria to cultured human cells and even commercialized for sale
in designer pets. Aside from basic localization assays, the two main uses of GFP

29

as a reporter focus on either the induction or suppression of GFP expression to
indicate interaction with an analyte of interest. One of the more popular assays
focusing on the suppressed expression of GFP is the determination of cell
viability. In these assays, cells expressing GFP are exposed to compounds of
interest and the severity of toxicity is determined by monitoring the decrease in
fluorescent expression (Choi, Deng et al. 2008). This allows researchers to
process a large number of samples very quickly in an automated fashion. As the
cells are killed or their metabolism is slowed by interaction with toxic substances,
the overall amount of fluorescence will decrease. This type of assay has the
added advantage of determining the amount of a given compound that will be
bioavailable to the organism being tested.
The inverse of this type of experiment is to induce the expression of GFP as a
positive result. In this case the gene encoding for GFP is placed under the
control of a genetic promoter that responds specifically to the analyte of interest.
This allows for visual detection when the cell is exposed to the target analyte. An
advantage of this type of experimental design is that the amount of fluorescence
produced can be correlated to the concentration of analyte, allowing for an
approximate quantification (Gvakharia, Bottomley et al. 2009). It is also possible
to use the fluorescence of GFP as a marker to isolate those members of the
community showing a response by using fluorescence activated cell sorting
(FACS) (Bumann and Valdivia 2007). Using GFP to confirm interaction with a
compound of interest, quantify the amount of exposure, and isolating exposed
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cells simultaneously illustrates its dynamic functionality in modern bioreporter
research.
Biosensor integration of GFP-based bioreporters, however, remains fairly
limited due to signal output by GFP being contingent upon an excitation light
source. Thus, these set-ups require one energy source to excite GFP and
another to measure GFP, and the associated complexity and bulkiness are often
not suitable for biosensor applications. There has been some application success
using fiber optic cables where one cable is used for excitation and another for
emission measurement. Shetty (Shetty, Ramanathan et al. 1999), for example,
constructed a GFP-based bioreporter sensitive to the monosaccharide Larabinose and entrapped it within a dialysis membrane tied to the tip of a fiber
optic bundle. Fibers terminating at a tungsten lamp served as the excitation
source while separate fibers terminating at a PMT served as the detector.
Immersing the reporter-entrapped sensor end of the fiber bundle in liquid was
then shown capable of detecting L-arabinose at varying concentrations. To
improve sensitivity, Knight (Knight, Goddard et al. 1999) bypassed fiber optics by
interfacing a PMT directly with a flow-cell containing a eukaryotic-based GFP
bioreporter sensitive to DNA damaging genotoxic compounds using an argon
laser to provide the excitation source. Realizing the necessity for miniaturization
and less complexity, new fluorescence detection techniques based on small
footprint biosensor compliant platforms are becoming somewhat available.
Complementary–metal–oxide–semiconductor (CMOS) photodetectors better
tuned to the green light signature provide enhanced detection (Yotter, Warren et
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al. 2004), as do avalanche photodiodes, while tightly focused laser beams
provide excitation down to the single cell level (Wells 2006). However,
incorporating all necessary components into a true biosensor format remains
challenging. Recently a 12 cm diameter microfluidics-based lab-on-a-compact
disk (CD) device that microcentrifugally moved and mixed microliter volumes of
water test samples with a GFP bioreporter sensitive to arsenic have been
created (Rothert, Deo et al. 2005) (Figure 5). Although sensing was
accomplished with a fiber optic probe positioned above the CD, the device could
likely be easily reconfigured to accommodate a chip-based sensor to promote further
miniaturization.
in vivo bioluminescent imaging (BLI)
Whole animal bioluminescent imaging (BLI) is progressively becoming more
widely applied by investigators from diverse backgrounds because of its low cost,
high throughput, and relative ease of operation in visualizing a wide variety of in
vivo cellular events (Baker 2010). The ability to visualize cellular processes or
other biological interactions without the requirement for animal subject sacrifice
allows for repeated imaging and releases investigators from the constraints of
considering their process of interest on a “frame-by-frame” basis using labeled
slides. In addition, the ability to continually monitor a single individual reduces
the amount of inter-animal variation and can reduce error, leading to higher
resolution and less data loss. With continuing advances in the hardware and
software required for performing these experiments, it is also becoming easier for
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Figure 5. Miniaturization of detection technologies allows for increased ease of use.
A) A lab-on-a-CD microfluidic device used in conjunction with GFP bioreporters sensitive towards
arsenic. B) A close-up view of the microfluidic channeling that permits sample and bioreporter
mixing. Originally published in (Rothert, Deo et al. 2005), reprinted with permission.
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researchers with little background in molecular imaging to obtain useful and
detailed publication-ready images.
The mainstays of BLI are the light generating luciferase enzymes such as
firefly luciferase, Renilla luciferase, Gaussia luciferase, Metridia luciferase,
Vargula luciferase, or bacterial luciferase (Thompson, Nagata et al. 1989; Wood,
Lam et al. 1989; Lorenz, McCann et al. 1991; Meighen 1991; Verhaegen and
Christopoulos 2002; Markova, Golz et al. 2004). Of these however, the firefly
and Renilla luciferases are the most popular for optical imaging. These
bioluminescent proteins are preferred over their fluorescent counterparts
because the lack of endogenous bioluminescent reactions in mammalian tissue
allows for near background-free imaging conditions whereas the prevalence of
fluorescently active compounds in these tissues can interfere with target
resolution upon exposure to the fluorescent excitation wavelengths required for
the generation of signal output.
Firefly luciferase (Luc), Renilla luciferase (RLuc), and bacterial luciferase (lux)
all exhibit distinct imaging characteristics ranging for the substrate required (if
any) to the wavelength at which their bioluminescent signal is produced. It is this
diversity that has lead to their popularity for in vitro BLI. While none of them
individually is suited to every experimental design, they can be interchanged and
sometimes used in combination to function in a wide variety of imaging
applications. The advantages and disadvantages of these reporter proteins as
they relate to their use in BLI are listed in Table 1.
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Table 1. Comparison of BLI reporter proteins.

Reporter
Advantages
Firefly and click • High sensitivity and low
beetle luciferase
signal-to-noise ratio
• Quantitative correlation
• D-luciferin
between signal strength and
substrate
cell numbers
• Low background in animal
tissues
• Variations of firefly
luciferase (stabilized and
red-shifted) and click beetle
luciferases (red and green)
are available
• Different colors allow multicomponent monitoring
Renilla and
• High sensitivity
Gaussia
• Quantitative correlation
luciferase
between signal strength and
cell numbers
• Coelenterazine • Stabilized and red-shifted
Renilla luciferase are
substrate
available
• Secretion of Gaussia
luciferase allows for subjectindependent
bioluminescence
measurement
Bacterial
luciferase

• High

sensitivity and low
signal-to-noise ratio
• Quantitative correlation
between signal strength and
cell numbers
• Fully autonomous system,
no requirement for addition
of exogenous substrate
• Noninvasive
• Stable signal
• Rapid detection permitting
real-time monitoring
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Disadvantages
• Requires exogenous
luciferin addition
• Fast consumption of
luciferin can lead to
unstable signal
• ATP and oxygen
dependent
• Currently not practical for
large animal models

• Requires

exogenous
coelenterazine addition
• Low anatomic resolution
• Increased background due
to oxidation of
coelenterazine by serum
• Oxygen dependent
• Fast consumption of
coelenterazine can lead to
unstable signal
• Currently not practical for
large animal models
• Bioluminescence

at 490 nm
prone absorption in animal
tissues
• Low anatomic resolution
• NADPH and oxygen
dependent
• Not as bright as other
luciferases
• Currently not practical for
large animal models

Optical properties of biological tissues
The unique constraints of performing data collection from within a living
medium must be considered in relation to any choice of reporter system. The
detection of a luminescent signal from within a tissue sample is dependent on
several factors, including the flux of photons from the reporter, the total number
of functional reporter cells in the sample, and the location of the reporter cells
within the tissue sample itself (Troy, Jekic-McMullen et al. 2004). In addition, the
visualization of the bioluminescent signal is dependent on the absorption and
scattering of that signal prior to detection. The scattering of a bioluminescent
signal cannot be controlled, however, changing its wavelength can alter the
absorption characteristics of the signal significantly. This is due to the fact that
the majority of luminescent absorption is the result of interaction of the signal with
endogenous chromophoric material. By moving to a more red-shifted emission
wavelength, where the levels of absorption within tissue are lower, it becomes
possible to measure a greater amount of signal intensity than would be possible
from an identical reporter with a lower, more blue-shifted emission wavelength
(Chance, Cope et al. 1998). For this reason, it is important to consider the
emission wavelength of a given reporter system, along with the other desired
attributes of that reporter, prior to its introduction into any experimental design.
For example, the bioluminescent signal from the lux reaction is produced at 490
nm. This is relatively blue-shifted as compared to the Luc-based bioluminescent
probes that display their peak luminescent signal at 560 nm. The shorter
wavelength of the lux-based signal has a greater chance of becoming attenuated
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within the tissue and therefore may not be as easily detected if it is used in
deeper tissue applications (such as intraperitoneal or intraorganeller injections),
and may require longer integration times to achieve the same level of detection
as a longer wavelength reporter would when injected subcutaneously.
Therefore, if short measurement times and low population level cell detections
are the goals of a particular experiment, a Luc-based reporter would be beneficial
compared to a lux-based reporter despite potential problems introduced through
substrate administration in the Luc system. However, if a near surface detection
of large cell populations (such as a subcutaneous tumor) was the end goal, the
effects of absorption and scattering could be overcome by the depth and position
of the reporter, thus allowing for selection of the more blue-shifted lux reporter
system.
Imaging equipment
The challenge of detecting and locating bioluminescent light emissions from
within living subjects has been met by several commercial suppliers of in vivo
imaging equipment (Table 2). A basic imaging system consists of a light-tight
imaging chamber into which the subject is placed and a high quantum efficiency
charged coupled device (CCD) camera, usually supercooled to less than -80°C
to reduce thermal noise, that collects emitted light. The camera typically first
takes a photographic image of the subject followed by a bioluminescent image.
When superimposed, regions of bioluminescence become mapped to the
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Table 2. Commercial manufacturers of in vivo imaging systems.

Company
Caliper Life Sciences
Berthold Technologies
Carestream
Photometrics
Li-Cor Biosciences
Cambridge Research &
Instrumentation
UVP

URL
http://www.caliperls.com/tech/optical-imaging/
http://www.berthold.com/ww/en/pub/home.cfm
http://www.carestreamhealth.com/in-vivoimaging-systems.html
http://www.photometrics.com/
http://www.licor.com/index.jsp
http://www.cri-inc.com/index.asp
http://www.uvp.com/
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subject’s anatomy for pinpoint identification of source emissions. Acquisition
times can range from a few seconds to several minutes depending on signal
strength. Software displays the image in a pseudocolored format and provides
the tools needed to quantify, adjust, calibrate, and background correct the
resulting image. Integrated gas anesthesia systems, heated stages, and
isolation chambers are typically available to accommodate animal handling.
The technology incorporated into in vivo imaging systems is rapidly advancing
to meet user needs in a greater diversity of application backgrounds. CCD
cameras are being replaced by more sensitive intensified CCD (ICCD) and
electron multiplying CCD (EMCCD) cameras that can manage acquisition times
of millisecond durations. These fast processing times along with powerful
software now permit real-time tracking of conscious, moving subjects (see, for
example, the IVIS Kinetic system from Caliper Life Sciences). Anesthesia can
have dramatic, unknown, and interfering effects on animals, and the ability to
image in its absence is a major step forward in in vivo imaging technology. In
addition, imaging systems are becoming better integrated with existing medical
technologies for multi-parameter analyses. For example, electrocardiogram
(ECG) or X-ray procedures can operate in parallel with imaging acquisition. The
ability of software to overlay and map these data to the bioluminescent image,
often as a 3D representation, offers unique opportunities to visualize
physiological status and kinetics.
The major drawback of in vivo imaging systems is their inability to detect
signal at tissue depths beyond a few centimeters. Without major advances in
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imaging sensitivity, either with the camera systems, the internal signal, or almost
certainly both in tandem, in vivo imaging applications may become limited solely
to small animals and the translational leap to humans will never occur. Rather
than relying on a camera to visualize the signal externally, it may be feasible and
potentially more practical to monitor the signal internally using implantable
sensors. Although not yet a viable technology, proof-of-concept
microluminometer integrated circuits of only a few square millimeters in size have
been developed and validated for bioluminescent signal acquisition
(Vijayaraghavan, Islam et al. 2007). These so-called bioluminescent bioreporter
integrated circuits, or BBICs, were specifically designed for capturing the 490 nm
bioluminescent light signal emitted by the bacterial lux system, and
accommodated on-chip transmitters for wireless data transmission. However,
effectively interfacing the microluminometers with the luciferase reporter systems
maintaining reporter viability, and implanting the chips remains challenging.
Common in vivo bioluminescent imaging modalities
Steady-state bioluminescent imaging

The classical hallmark of BLI is steady state imaging, a process whereby
bioluminescently tagged cells are imaged over time to determine if light output is
increasing or decreasing compared to the initial state. In this type of imaging,
either a gain or loss of signal can be the desired result depending on the
experimental design. Commonly, bioluminescent cells are injected into an
animal model to determine the kinetics of tumorigenesis and growth. The use of
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BLI as a substitute for mechanical or histological measurement of tumors has
increased rapidly in recent years as it does not entail high levels of animal
subject sacrifice nor tedious histological analysis, and can overcome the loss of
accuracy associated with physical analysis due to the contribution of edema and
necrotic centers to overall tumor size (Vaupel, Kallinowski et al. 1989). In
addition, by monitoring tumor growth using BLI, an investigator can track
changes within individual animals over time without requiring the subject to be
sacrificed. This reduces the amount of intra-animal variability and can improve
the detection of significant results.
In the opposite direction, decreases in bioluminescent expression can be
used to quickly and efficiently perform drug efficacy screening. The same
logistical concerns that have propelled BLI forward as the tool for choice for
tumor monitoring are also making it the preferred choice for the screening of new
compounds directed at tumor suppression or infection control. In addition, the
use of mixed culture or whole animal models can more closely mimic the target
microenvironmental conditions that may alter the compound’s activity. As one
example, McMillin et al. (McMillin, Delmore et al. 2010) illustrated that high
throughput scalable mixed cell cultures with Luc tagged cancer cells can identify
anti-cancer drugs that are specifically effective in the tumor microenvironment
early in the discovery pipeline, thereby aiding in their prioritization for further
study in ways not previously possible.
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Multi-reporter bioluminescent imaging

In a basic experimental design, multi-reporter BLI is performed by
simultaneously monitoring for expression of two or more divergent luciferase
proteins. This is made possible because all of the characterized luciferase
proteins have divergent bioluminescent emission wavelengths. This type of
experimental design is especially useful when used to monitor potentially codependent, or inter-dependent protein expression such as that expressed during
the maintenance of circadian rhythm. Here, the expression of multiple genes can
be monitored in real time, without the need to expose cells to potentially
influential doses of excitation light wavelengths as would be required for imaging
using fluorescent targets (Honma, Yoshikawa et al.). Even when expression of
the individual genes of interest is static, sequential imaging of multiple luciferase
proteins provides a convenient method for localizing expression profiles of each
gene in vivo (Heikkila, Vaha-Koskela et al. 2010).
The work of Audigier and colleagues (Audigier, Guiramand et al. 2008)
demonstrates how imaging multiple bioluminescent reporters can be an
opportune way to monitor translational dynamics using the function of the
fibroblast growth factor two internal ribosomal entry site on neural development
as a model. To determine the associated ratios of cap-dependent to capindependent translation, they cloned the RLuc gene upstream of the site and the
Luc gene downstream. By doing so, they were able to quantify and compare the
levels of expression of each reporter protein independently from the same
sample, helping to reduce sampling error.
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Multi-component bioluminescent imaging

Similar to multi-reporter BLI, multi-component BLI relies on the co-expression
of an alternate imaging construct, however, in this case the secondary construct
is not itself bioluminescent. Classically, the luminescent emission signal of a
substrate amended luciferase protein can be harnessed to act as the excitation
signal for an associated fluorescent reporter protein, negating the requirement for
treatment with a background stimulating exogenous light source. This process,
known as bioluminescence resonance energy transfer (BRET) occurs naturally in
the sea pansy Renilla reniformis and other marine animals (Ward and Cormier
1978), but can be used in research settings to boost the luminescent signal of a
bioluminescent reporter, or, more popularly, to determine the interaction of two
components of interest within a given system.
In some cases, the secondary component is not a fluorescent compound but
rather a non-independently functional domain of the luciferase protein itself.
These types of constructs are easily created using reporters such as Luc that
have distinct N (N-Luc) and C (C-Luc) terminal domains joined by a linker region.
These types of protein structures lend themselves nicely to separation into
distinct components that, when brought together, can form a functional luciferase
protein.
First described by Paulmurugan et al. (Paulmurugan, Umezawa et al. 2002),
this process takes advantage of the lack of a bioluminescent signal in small
animal tissue samples. The individual N and C terminal components of the Luc
protein are not capable of producing light independently of one another, however,
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when they were independently tethered to two proteins known to interact
strongly, the researchers were able to demonstrate that bioluminescence could
be restored upon substrate amendment. The complementation of a single
luciferase protein as opposed to the adjoinment of a luciferase with a fluorescent
partner does not require the pair matching of a luciferase/fluorescent reporter
with overlapping emission/excitation wavelengths, and can permit covisualization with other reporters in a single subject to permit multi-localization of
groups of proteins.
Bioluminescence as a supplementary imaging technique

As the technology for small animal imaging continues to increase in power
and availability, there is an increasing movement towards combining multiple
imaging techniques to improve the amount of detail that can be obtained from a
single subject. While no single imaging technique can provide an investigator
with a comprehensive picture of the system as a whole, the combination of
multiple techniques such as computed tomography (CT), positron emission
tomography (PET), and BLI can help to “fill in the gaps” left by each approach in
a rapid, sequential manner. The development of trimodal fusion proteins that are
capable of simultaneously acting as a signal for fluorescence, bioluminescence,
and PET, and the introduction of combined clinical PET/CT scanners has made it
possible to obtain more information from a single animal subject than was
previously believed possible (Deroose, De et al. 2007).
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CHAPTER II
Demonstration Of Autonomous Bioluminescent Production In
The Mammalian Cellular Background

Introduction
In vivo optical imaging is becoming increasingly utilized as a method for
modern biomedical research. This process, which involves the non-invasive
interrogation of animal subjects using light emitted either naturally from a
luciferase protein or following excitation of a fluorescent protein or dye, has been
applied to the study of a wide range of biological processes such as gene
function, drug discovery and development, cellular trafficking, protein-protein
interactions, and especially tumorigenesis and cancer treatment (Contag and
Bachmann 2002) . While the detection limits and resolution of charge coupled
devices (CCDs) has increased greatly in recent years (Oshiro 1998), there have
been relatively few introductions of improved imaging compounds that function
as light production centers within an animal subject in vivo.
Generally, the currently available imaging compounds can be divided into
two classes: those containing luciferase proteins (capable of producing
bioluminescent light without exogenous excitation) and those containing
fluorescent compounds (dyes or proteins that require an initial excitation followed
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by emission at a given wavelength). For mammalian-based whole animal
imaging, fluorescent compounds are limited due to high levels of background
fluorescence from endogenous biological structures upon excitation (Tsien
1998). Although dyes have been developed and employed that fluoresce in the
near infrared wavelengths (Bloch, Lesage et al. 2005; Kalchenko, Shivtiel et al.
2006) where light absorption is lowest in mammalian tissues, they can become
increasingly diffuse during the process of cellular division, negating their
usefulness in long term monitoring studies (Contag and Bachmann 2002) . In
contrast, luciferase proteins are highly amenable towards in vivo optical imaging
(referred to as bioluminescent imaging or BLI) because they produce a
controllable light signal in cells with little to no background bioluminescence, thus
allowing for remarkably sensitive detection (Zhao, Doyle et al. 2005). While
historically the luciferase proteins used have been based on beetle luciferases
(i.e., firefly or click beetle luciferase) or marine aequorin-like proteins (those that
utilize coelenterazine), these each possess disadvantages when applied to whole
animal BLI. For example, the popular firefly luciferase protein is heat labile when
incubated under whole animal BLI imaging conditions, and can display a half life
as short as 3 min in its native state at 37°C (Baggett, Roy et al. 2004).
Coelenterazine-stimulated luciferases are similarly handicapped in regards to
long-term monitoring, as it has been reported that their rapid uptake of
coelenterazine necessitates prompt imaging following substrate injection
(Bhaumik and Gambhir 2002). Applications of both these luciferase systems
also suffer from the drawback that they require addition of an exogenous
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substrate to produce a detectable light signal. This current work reports for the
first time that a modified bacterial luciferase gene cassette can be expressed in
mammalian cells in culture or in whole animal BLI without the use of exogenous
substrates or coincident infection with a bacterial host, thus overcoming the
limitations imposed by currently available luciferase-based BLI assays.
Setting the bacterial bioluminescence system apart from other
bioluminescent systems such as firefly luciferase and aequorin is its ability to
self-synthesize all of the substrates required for the production of light. While the
luciferase component is a heterodimer formed from the products of the luxA and
luxB genes, its only required substrates are molecular oxygen, reduced riboflavin
phosphate (FMNH2), and a long chain aliphatic aldehyde. Oxygen and FMNH2
are naturally occurring products within the cell while the luxCDE gene products
produce and regenerate the aldehyde substrate using endogenous aliphatic
compounds initially targeted to lipid biogenesis. To produce light, the luciferase
protein first binds FMNH2, followed by O2, and then the synthesized aldehyde.
This allows the lux cassette to utilize only endogenous materials to form an
intermediate complex that then slowly oxidizes to generate light at a wavelength
of 490 nm as a byproduct (Meighen 1991). The overall reaction can be
summarized as:

FMNH2 + RCHO + O2  FMN + H2O + RCOOH + hv490nm
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Realizing the distinct advantages bacterial luciferase would afford as a
eukaryotic reporter, many groups have attempted to express the luciferase
(luxAB) component of the lux system using either fusion proteins (Escher, Okane
et al. 1989; Kirchner, Roberts et al. 1989; Almashanu, Musafia et al. 1990;
Pazzagli, Devine et al. 1992) or multiple plasmids (Koncz, Olsson et al. 1987;
Olsson, Escher et al. 1989), but with minimal success over the last twenty years.
Although the use of lux in the study of bacterial infection of a mammalian host
has been demonstrated using whole animal BLI (Contag, Contag et al. 1995), its
functionality has not been demonstrated outside of a bacterial host until now.
Recently, successful expression of a mammalian optimized luciferase dimer in an
HEK293 cell line has provided for the limited use of lux as a mammalian
bioluminescent reporter system, although the addition of luciferin in a manner
similar to firefly luciferase is still required (Patterson, Dionisi et al. 2005). To fully
exploit the advantages of bacterial luciferase, all five genes (luxCDABE) of the
lux operon must be expressed simultaneously. Here it is demonstrated that
codon-optimized, poly-bicistronic expression of the full lux cassette produces all
of the products required for autonomous bioluminescent production in a
mammalian background. It is further demonstrated that cells expressing the full
lux cassette can be applied towards whole animal BLI without the need for
substrate addition, thus overcoming the limitations imposed by currently available
luciferase-based whole animal BLI probes.
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Materials And Methods
Strain maintenance and growth
Escherichia coli cells were routinely grown in Luria Bertani (LB) broth with
continuous shaking (200 rpm) at 37°C. When required, kanamycin or ampicillin
was used at final concentrations of 40 and 100 µg/ml, respectfully, for selection
of plasmid containing cells. Mammalian cell lines were propagated in Eagle’s
modified essential medium (EMEM) supplemented with 10% fetal bovine serum,
0.01 mM non-essential amino acids, and 0.01 mM sodium pyruvate. Cell growth
was carried out at 37°C in a 5% CO2 environment and cells were passaged every
3 - 4 d upon reaching 80% confluence. Neomycin and/or zeocin were used for
selection of transfected cells at concentrations of 500 µg/ml and 200 µg/ml,
respectfully, as determined by kill curve analysis, for each antibiotic.
Codon optimization of the bacterial bioluminescence genes
Codon usage patterns in the luxCDE genes for P. luminescens and the flavin
reductase gene (frp) from V. harveyi were compared to the highest 10% of
expressed genes as represented in GenBank. Silent mutations at the DNA level
that would alter native codon usage were plotted to more closely mimic the
preferred mammalian codons while maintaining 100% amino acid identity with
the bacterial protein sequences. When multiple codons were preferred in equal
or near equal frequencies by mammalian genes, the codon for the optimized
sequence was randomly selected from the available options. These optimized
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sequences were submitted and synthesized de novo by GeneArt and returned as
synthetic DNA constructs inserted into unique KpnI and SacI restriction sites in
pPCR-Script vectors (GeneArt). Codon-optimized versions of each gene were
compared to their wild-type counterpart for predicted translational efficiency using
the freely available GENSCAN software at http://genes.mit.edu. All sequences
were deposited to GenBank under the following accession numbers GQ850533
(codon-optimized luxC), GQ850534 (codon-optimized luxD), GQ850535 (codonoptimized luxE), and GQ850536 (codon-optimized frp).
Vector construction
Previously described (Patterson, Dionisi et al. 2005) P. luminescens luxA and
luxB genes partially codon-optimized for expression in human cell lines were
obtained as a bicistronic operon in a pIRES vector (Clontech) and designated
pLuxAB. This vector includes an internal ribosomal entry site (IRES) for increased
translation of downstream gene insert. The remaining P. luminescens genes
(luxC, luxD, luxE) and the flavin reductase gene (frp) were used in either their
wild-type (wt) or codon optimized (co) states. coluxC was cloned into multiple
cloning site (MCS) A of the pIRES vector using the unique NheI and EcoRI
restriction sites (Figure 1 A-C). The coluxE gene was then inserted into MCS B
using the unique SalI and NotI restriction sites. This entire coluxC-IRES-coluxE
sequence was then removed and ligated into pBudCE4.1 (Invitrogen) behind the
human elongation factor 1α (EF-1α) promoter using unique XhoI and SfiI
restriction sites. A second pIRES vector was constructed by adding the coluxD
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Figure 6. Schematic showing construction and expression of the full lux cassette using a
two-plasmid system.
The two-plasmid system takes advantage of IRES-based bicistronic expression to drive
transcription/translation of all the genes required for autonomous bioluminescent production. (A)
The pLuxAB plasmid contains the genes responsible for production of the luciferase protein.
Individual luxA and luxB genes were removed from their respective vectors and ligated into the
pIRES vector using the unique NheI (N) and EcoRI (E) or SalI (S) and NotI (Nt) restriction sites.
(B) The pLuxCDEfrp plasmid expresses the genes required for production and regeneration of the
aldehyde and FMNH2 substrates. The individual luxE and luxC genes were cloned into a pIRES
vector using the unique NotI (Nt) and SalI (S) or NheI (N) and EcoRI (E) restriction sites. (C) A
second pIRES vector was created that contained the luxD and frp genes inserted at the same
sites. The entire luxC-IRES-luxE fragment was then inserted under the control of the EF1-α
promoter in pBudCE4.1 using the unique XhoI (X) and SfiI (Sf) restriction sites, while the luxDIRES-frp fragment was inserted under the control of the CMV promoter using the unique PstI (P)
and BamHI (B) restriction sites. Originally published in (Close, Patterson et al. 2010).
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gene to MCS A via the unique NheI and EcoRI restriction sites and the addition
of cofrp to MCS B using the unique SalI and NotI restriction sites. This entire
coluxD-IRES-cofrp sequence was then inserted behind the pBudCE4.1 human
cytomegalovirus immediate early promoter (CMV) using the unique PstI and
BamHI restriction sites to create pLuxCDEfrp:CO. This process was repeated
using wild-type codon usage versions of each of the genes to generate an
identically oriented, but non-codon-optimized, vector referred to as
pLuxCDEfrp:WT.
Mammalian cell transfection
Transfection was carried out in six-well Falcon tissue culture plates (ThermoFisher). HEK293 cells stably expressing the pLuxAB vector were passaged into
each well at a concentration of approximately 1 × 105 cells/well and grown to 90 –
95% confluence in complete medium as described above. pLuxCDEfrp:CO and
pLuxCDEfrp:WT plasmid vectors were purified from 100 ml overnight cultures of E.
coli using the Wizard Purefection plasmid purification system (Promega). On the
day of transfection, cell medium was removed and replaced and vector DNA was
introduced using Lipofectamine 2000 (Invitrogen).
Selection of stable bioluminescent cell lines

Twenty-four h post-transfection, the medium was removed and replaced with
complete medium supplemented with the appropriate antibiotic. Selection of
successfully transfected clones was performed by refreshing selective medium
every 4 – 5 d until all untransfected cells had died. At this time, colonies of
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transfected cells were removed by scraping, transferred to individual 25 cm2 cell
culture flasks, and grown in complete medium supplemented with the appropriate
antibiotics.
Benchtop luminescent detection
Protein extraction

Total protein was extracted from co-transfected pLuxCDEfrp:CO/pLuxAB and
pLuxCDEfrp:WT/pLuxAB cell lines using a freeze/thaw procedure. Cells were first
grown to confluence in 75 cm2 tissue culture flasks, then mechanically detached
and resuspended in 10 ml of PBS. Following collection, cells were washed twice
in 10 ml volumes of PBS, pelleted and resuspended in 1 ml PBS. These 1 ml
aliquots of cells were subjected to three rounds of freezing in liquid nitrogen for
30 sec, followed by thawing in a 37°C water bath for 3 min. The resulting cell
debris was pelleted by centrifugation at 14,000g for 10 min and the supernatant
containing the soluble protein fraction was retained for analysis.
Bioluminescent detection

Bioluminescence was measured using an FB14 luminometer (Zylux) with a 1
sec integration time. To prepare the sample for in vitro bioluminescent
measurement, 400 µl of the isolated protein extract was combined with 500 µl of
either oxidoreductase supplemented light assay solution containing 0.1 mM
NAD(P)H, 4 µM FMN, 0.2% (w/v) BSA and 1 U of oxidoreductase protein isolated
from V. fischeri (Roche), or oxidoreductase deficient light assay solution (distilled
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water substituted for the 1 U of oxidoreductase protein). Following the initial
bioluminescent reading, samples were amended with 0.002% (w/v) n-decanal
and the readings were continued to determine if additional aldehyde could
increase light output. All bioluminescent signals were normalized to total protein
concentration as determined by BCA protein assay (Pierce) and reported as
relative light units (RLU)/mg total protein. All sample runs included processing of
cell extracts from HEK293 cells stably transfected with pLuxAB as a control for
light expression upon amendment. To prepare cells for in vivo bioluminescent
measurement, the total cell contents of a 75 cm2 tissue culture flask were
resuspended in 1 ml of Dulbecco’s Modified Eagle Medium (DMEM) without
phenol red supplemented with 10% fetal bovine serum, 0.01 mM non-essential
amino acids, and 0.01 mM sodium pyruvate. A 15 µl aliquot of cells was
removed and counted using a hemocytometer to allow all values to be
normalized to viable cell counts. The remainder was used directly for
bioluminescent measurement using the FB14 luminometer with a 1 sec
integration time.
Growth curve analysis
Cells were harvested during exponential growth from a 75 cm2 tissue culture
flask and split into four 25 cm2 tissue culture flasks at ~5 × 104 cells/cm2. At 24 h
intervals, the cells were detached from the flasks by mechanical agitation and
resuspended in 3 ml phosphate buffered saline (PBS). A 15 µl aliquot was
removed and diluted into an equal volume of trypan blue. Cells were counted
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using a hemocytometer and the average of 4 counts was used to determine the
total viable cell number.
Bioluminescent detection from cell culture
Determination of minimum detectable cell number in culture

Actively growing HEK293 cells expressing pLuxCDEfrp:CO/pLuxAB were
trypsinized and harvested from 75 cm2 tissue culture flasks and counted using a
hemocytometer. Using a 24-well tissue culture plate, groups of approximately
either 500,000, 250,000, 100,000, 50,000, 40,000, 30,000, 20,000, 10,000,
5,000, 2,000, or 1,000 cells were plated in each of three wells in 1 ml of DMEM
without phenol red supplemented with 10% fetal bovine serum, 0.01 mM nonessential amino acids, and 0.01 mM sodium pyruvate. As a negative control,
three wells were supplemented with 1 ml of media without cells to observe
background. Average radiance in photons/sec/cm2/sr was determined in the IVIS
Lumina using a 10 min integration time 15 h after plating.
Correlation of cell population size and bioluminescent output

To establish the relationship of cell number to bioluminescent flux, the
average radiance values from cells producing a visible light signal under the
conditions above were correlated to cell number.
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Bioluminescent detection as a target for small animal imaging
Ethics statement

All animal work was performed in adherence to the institutional guidelines put
forth by the animal care and use committee of the University of Tennessee. All
animal research procedures were approved by the University of Tennessee
Animal Care and Use Committee (protocol number 1411) and were in
accordance with National Institutes of Health guidelines.
Cellular harvesting and preparation for injection

Actively growing HEK293 cells expressing pLuxCDEfrp:CO/pLuxAB were
trypsinized and harvested from 225 cm2 tissue culture flasks and counted using a
hemocytometer. Using the average of two counts with the hemocytometer, cells
were resuspended at approximately 5 × 106 cells / 100 µl PBS in a 1.5 ml tube
(Eppendorf). Cells were maintained at 37°C in a water bath until required for
injection.
Whole animal bioluminescent imaging

Five week old nu/nu (nude) mice were anesthetized via isoflurane
inhalation until unconscious. Subjects were then subcutaneously injected with ~5
× 106 HEK293 cells co-transfected with pLuxCDEfrp:CO/pLuxAB in a 100 µl volume
of PBS. An equal number of HEK293 cells (~5 × 106) containing only pLuxAB
were injected as a negative control in the same volume. The subject was imaged
immediately following the injections and average radiance was determined over
integration times of 1 to 10 min at intervals over a 30 min period.
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Determination of minimum detectable cell number following subcutaneous injection

Six week old nude mice were anesthetized via isoflurane inhalation until
unconscious and then injected with decreasing numbers of HEK293 cells
expressing pLuxCDEfrp:CO/pLuxAB. In a preliminary experiment, animals were
subcutaneously injected at 4 separate locations with 5 million, 2.5 million, 1
million, and 500,000 cells, each in a volume of 100 µl PBS. The subject was
imaged for 10 min following injection of the final group of cells. Minimum
detectable cell numbers were further delineated in a second round of injections in
a fresh mouse model using cell concentrations of 500,000, 250,000, 50,000, and
25,000 cells in 100 µl PBS and identically imaged.

Results
Benchtop bioluminescent detection from stably transfected HEK293 cells
To determine and compare the bioluminescent output kinetics of HEK293
cells containing the luxCDEfrp genes in either their wild-type (pLuxCDEfrp:WT) or
codon-optimized (pLuxCDEfrp:CO) form, cells were propagated under identical
conditions, harvested, and resuspended directly in a cuvette for measurement of
bioluminescence against a standard photomultiplier tube interface. Cells
containing pLuxCDEfrp:CO/pLuxAB showed an average bioluminescent production
12-fold greater than background in the presence of untransfected control cells
and 9-fold greater than the bioluminescent production of their wild-type
counterparts (Table 3). The superior bioluminescent production by cells
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Table 3. Bioluminescent production from unsupplemented HEK293 cells expressing P.
luminescens lux genes.

Cell Line

Bioluminescent Detection
(RLU/sec)

Cell Free Media

745 (± 63)

Untransfected
HEK293 Cells
HEK293
+ pLuxAB
+ pLuxCDEfrp:WT
HEK293
+ pLuxAB
+ pLuxCDEfrp:CO

655 (± 44)
884 (± 44)
7600 (± 1241)
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containing pLuxCDEfrp:CO/pLuxAB validates our dual plasmid, bicistronic, codonoptimized expression strategy and substantiates our hypothesis that the full
bacterial lux cassette can be designed for functional autonomous expression in a
mammalian cell line.
Growth curve analysis
To determine if the maintenance and expression of full complements of lux
genes was detrimental to cellular growth rates in HEK293 cells, the rates of
growth among wild-type, pLuxCDEfrp:CO, and pLuxCDEfrp:WT containing cells was
monitored over the course of a normal passage cycle. It was hypothesized that
any adverse effects from production of aldehyde or increased presence of
FMNH2 resulting from the expression of the pLuxCDEfrp plasmid would result in a
slowed growth rate relative to the wild-type HEK293 cell line. No significant
difference in the rates of growth was observed among any of the cell lines tested
(Figure 7), suggesting that any adverse effects resulting from expression of the
luxCDEfrp genes are minimal in regards to cellular growth and metabolism.
Bioluminescent detection from cell culture
For a lux-based system to function as a reporter in whole animal BLI, the
resulting signal must be detectable using commercially available equipment
designed for this purpose and be easily distinguishable from background light
emissions. To determine if this was the case in HEK293 cells expressing full lux
cassettes, approximately equal numbers of cells containing either codonoptimized or wild-type lux genes were plated in 24-well tissue culture plates and
59

Figure 7. Growth rates of lux-containing HEK293 cells.
Growth curve analysis of cells containing no plasmids (negative control, untransfected HEK293)
or cells containing pLuxAB co-transfected with either pLuxCDEfrp:WT or pLuxCDEfrp:CO. Cells were
grown over a 96 h period until 80% confluent, representing normal passage conditions. Values
are the average of three trials and are reported with the standard error of the mean. Originally
published in (Close, Patterson et al. 2010).
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compared with untransfected cells as a negative control for background. The
bioluminescent signal from cells co-transfected with codon-optimized luxCDEfrp
was differentially detectable from background using a 10 sec integration time
(Figure 8A) and increased in magnitude with no appreciable increase in
background up to integration times of 30 min (Figure 8 B-F). To determine the
maximal duration of the bioluminescent signal during constitutive expression
under experimental conditions, approximately equal numbers of HEK293 cells in
either their untransfected state or containing pLuxAB co-transfected with either
pLuxCDEfrp:WT or pLuxCDEfrp:CO were continually monitored for bioluminescence
production (Figure 8G) in an IVIS Lumina imaging system using a stage
temperature of 37°C to mimic as closely as possible their normal growth
conditions. Cells containing the lux cassette genes demonstrated bioluminescent
output over an approximate three-day period without any exogenous input. Peak
bioluminescent output was achieved between 12 and 13 h for both the codonoptimized and wild-type containing cell lines, however, following peak
bioluminescent output a slow decrease in bioluminescent production over time
was observed. This decrease is presumably due to a combination of the inability
to reliably regulate the air temperature, CO2 levels, and humidity in the imaging
system, and the continued depletion of nutrients from the media during the
normal process of cellular growth and metabolism. While the bioluminescent
output of cells containing pLuxCDEfrp:WT/pLuxAB was of a lesser magnitude than
that of their codon-optimized counterparts over this time period, their
bioluminescent expression profiles were similar under the same conditions,
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Figure 8. in vitro bioluminescent imaging of lux cassette containing cells.
pLuxCDEfrp:CO/pLuxAB containing (CO), pLuxCDEfrp:WT/pLuxAB containing (WT), and untransfected
negative control (NEG) HEK293 cells were plated in 24-well tissue culture plates and integrated
for (A) 10 sec, (B) 1 min, (C) 5 min, (D) 10 min, (E) 15 min, and (F) 30 min. Bioluminescence
from cells co-transfected with pLuxCDEfrp:CO/pLuxAB was distinguishable from background in the
presence of untransfected cells after 10 sec and showed no increase in background detection
even after a 30 min integration time. Long term in vitro expression (G) demonstrates the
temporal longevity of the signal without exogenous amendment. The minimum detectable
number of bioluminescent cells was determined (H) by plating a range of cell concentrations in
equal volumes of media in triplicate (downward columns) in an opaque 24-well tissue culture
plate. The minimum number of cells that could be consistently detected was approximately
2
20,000. Average radiance was shown to correlate with plated cell numbers (I), yielding an R
value of 0.95275. Originally published in (Close, Patterson et al. 2010).
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suggesting that the codon-optimization process had not significantly altered the
function of the lux proteins in vivo.
To be useful as an optical reporter, cells expressing bioluminescence must
be detectable over a dynamic population range. To determine the minimum
detectable cell number, HEK293 cells containing pLuxCDEfrp:CO/pLuxAB at
concentrations ranging from 1,000 to 500,000 cells were plated in triplicate in
equal volumes of media over a constant surface area and imaged over a 10 min
integration time. The minimum number of cells reliably detected above
background was approximately 20,000 although some visible signal was
detected at approximately 10,000 cells in at least one case (Figure 8H).
A major advantage imparted by the use of bioluminescent or fluorescenttagged reporter cells is that they allow an investigator to approximately quantify
the population size of those cells noninvasively in a living host. For this
approximation to be made using a lux-based system, it must be demonstrated
that the bioluminescent flux of the cell population correlates tightly with the
overall population size. To determine if this is the case in HEK293 cells
constitutively expressing codon-optimized bacterial luciferase genes, the average
radiance of cells producing a visibly detectable bioluminescent signal was
determined over cell concentrations ranging from 500,000 to 1,000 cells. The
average radiance closely correlated with the number of cells present (R2 =
0.95275) over all visibly detectable cell numbers tested (Figure 8I).
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Bioluminescent detection from a small animal model system
Although lux has been previously used in whole animal BLI (Contag, Contag
et al. 1995), this is the first demonstration of its functionality outside of a bacterial
host. Bacteria-free expression of this genetic system assures that the results
seen are directly related to the object of study, and are not artifacts of a hostpathogen interaction stemming from the previously required bacterial infection.
To demonstrate this functionality, 5 week old nude mice were subcutaneously
injected with HEK293 cells co-transfected with pLuxCDEfrp:CO/pLuxAB or pLuxAB
alone and imaged. Cells containing only pLuxAB were injected as a negative
control to determine if the substrates supplied by the luxCDEfrp genes in the
pLuxCDEfrp plasmid were capable of being scavenged from endogenously
available stocks within the host in the presence of the luciferase dimer formed by
the products of the luxAB genes on the pLuxAB plasmid. Bioluminescent signal
emission from injected pLuxCDEfrp:CO/pLuxAB HEK293 cell lines was detectable
immediately (< 10 sec) following injection (Figure 9A), mirroring the results of
subcutaneous tumor mimic bioluminescence from firefly luciferase (FLuc)-tagged
(Inoue, Kiryu et al. 2009) and Renilla luciferase (RLuc)-tagged (Bhaumik and
Gambhir 2002) cells following intravenous (IV) injection of their D-luciferin or
coelenterazine substrates, respectfully. Following injection, the lux signal
increased slowly in intensity over the full 60 min course of the assay (Figure 9B).
This is in contrast to FLuc-based bioluminescent signals that exhibit a steady
decline over the same period following IV injection of D-luciferin to a level ~20%
of their initial intensity (Inoue, Kiryu et al. 2009). RLuc bioluminescence is even
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Figure 9. in vivo bioluminescent imaging using HEK293 cell expression of mammalianadapted lux.
(A) HEK293 cells containing the mammalian adapted pLuxCDEfrp:CO/pLuxAB cassette (Full) were
subcutaneously injected into nude mice and imaged. Detection occurred nearly immediately (<
10 sec) post-injection and remained visible up to the 60 min time point of the imaging assay.
HEK293 cells containing only the pLuxAB plasmid (luxAB) were subcutaneously injected into the
same mouse as a negative control. Note that the automatic scaling of signal intensity differs
among images, therefore creating the false appearance that image intensity is decreasing after
the 10 min post-injection time point when in fact it continually increases as shown in panel (B).
(C) Comparison of mammalian-adapted lux-based bioluminescence from HEK293 cells versus
published data on the expression of FLuc (*(Inoue, Kiryu et al. 2009)) and RLuc (**(Bhaumik and
Gambhir 2002)) tagged cells over the 60 min course of the assay. (D) Upon termination of the
assay 60 min post injection, the bioluminescent signal from HEK293 cells expressing the full
complement of lux genes was detectable using an integration time as low as 30 sec. (E)
Subcutaneous injection of HEK293 cells containing pLuxCDEfrp:CO/pLuxAB at concentrations
ranging from 500,000 to 25,000 cells in 100 µl volumes of PBS demonstrated a tested lower limit
of detection of 25,000 cells using a 10 min integration time. MPI, minutes post injection.
Originally published in (Close, Patterson et al. 2010).
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more temporally limited and subsides within 5 min following IV injection of
coelenterazine (Bhaumik and Gambhir 2002) (Figure 9C). In contrast, the lux
bioluminescent signal remained detectable 60 min after injection using
integration times as low as 30 sec (Figure 9D). Conversely, FLuc signals are
asymptotically approaching their minimum (Inoue, Kiryu et al. 2009) and RLuc
signals have become fully attenuated (Bhaumik and Gambhir 2002) by 30 min,
thus making imaging at all but the shortest post-injection incubation times
impossible (Figure 9C). It is important to note that the duration of the
bioluminescent signal in FLuc containing systems can be extended by using a
subcutaneous or intraperitoneal injection of luciferin, however, each injection
route also produces a different bioluminescent emission profile over time (Inoue,
Kiryu et al. 2009). Because they forgo the addition of exogenous substrates to
trigger bioluminescence, lux-based systems are not subject to these effects. The
lack of a signal after injection of cells expressing only pLuxAB at any of the time
points sampled (Figure 9) confirms that the luciferase dimer alone is not capable
of producing unintended bioluminescence above the background levels of light
detection by scavenging endogenously available substrates. These results
demonstrate the utility of the lux system in providing bioluminescent data on
relatively prolonged time scales without the potentially error-inducing requirement
of disturbing the experimental environment to invasively inject additional luciferin
substrate.
Having illustrated the ability to reliably detect at least 20,000 cells in a
tissue culture setting (Figure 8H), the minimum detectable number of cells in
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small animal models remained to be determined. The detection of
bioluminescent cells following subcutaneous injection is more difficult than
detection in a culture setting due to the increased presence of chromophoric
material leading to higher absorption of emitted photons as they must travel
through more tissue to reach the detector. Subcutaneous injections of
decreasing numbers of cells into a nude mouse model revealed that the
introduction of at least 25,000 cells was capable of producing a detectable signal
(Figure 9E). As predicted from the correlation of cell number to bioluminescent
flux, injection of higher cell concentrations produced larger bioluminescent
signals over identical integration times.

Discussion
Development of the lux cassette into a functional and autonomous
mammalian bioluminescent system provides researchers a unique new tool that
allows for real-time monitoring of bioluminescence from whole animals or cell
cultures without exogenous substrate addition or cell lysis. The first step in the
creation of this reporter was the functional demonstration of the luciferase
heterodimer formed by the luxAB genes (Patterson, Dionisi et al. 2005). This set
the stage for the use of lux in eukaryotic cells as a non-autonomous reporter
system via the addition of aldehyde. Since that time, the production of aldehyde
has been demonstrated in S. cerevisiae (Gupta, Patterson et al. 2003), leading to
the development of the first eukaryotic lux-based autonomous reporter system.
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Here it has been demonstrated for the first time that expression of codonoptimized forms of the luxCDE genes from P. luminescens and the frp gene from
V. harveyi are capable of producing sufficient levels of the aldehyde and FMNH2
substrates required to drive light production autonomously in mammalian cells. It
is further demonstrated that these bioluminescent cells can be applied in whole
animal BLI without the need for substrate addition.
While the addition of luxCDEfrp to cells containing luxAB demonstrates light
emission at a level 12-fold greater than background (Table 3), it remained to be
determined if the associated increase in aldehyde production would be cytotoxic,
as had been demonstrated in luxAB containing S. cerevisiae and Caenorhabditis
elegans cells (Hollis, Lagido et al. 2001). If this scenario was determined to be
true, the increased presence of aldehyde may therefore cause those cells
capable of most efficiently producing aldehyde to inhibit their own growth,
mimicking the effects of antibiotic selection and causing them to be out-competed
in culture by cells expressing lower levels of aldehyde production. This
investigation revealed no significant variation among the growth rates of
untransfected HEK293 cells or those expressing either pLuxCDEfrp:WT/pLuxAB or
pLuxCDEfrp:CO/pLuxAB at levels capable of supporting continuous bioluminescent
production (Figure 7). These cells are necessarily producing the required
aldehyde substrate as demonstrated by their constitutive bioluminescent
production, but do not show a detectable difference in their rate of growth when
compared to cells that are grown under identical conditions but without the
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luxCDE genes required for the production and maintenance of the aldehyde
substrate.
When these codon-optimized lux containing HEK293 cells were used in cell
culture, concentrations of approximately 20,000 cells were reliably detected in 1
ml of media immediately using a 10 min integration time (Figure 8H). Increasing
cell numbers in the same volume and area correlated with measured levels of
bioluminescence emission, allowing one to predict the total cell number in a
given sample from the measured average radiance (Figure 8I) and permitting
non-invasive estimation of target size based on bioluminescent measurements.
When the same bioluminescent cell lines were applied in whole animal BLI,
the low levels of detectable background signal and deficit of endogenous
bioluminescent production associated with mammalian cells enabled lux-based
bioluminescence to remain detectable. This sensitivity was demonstrated both in
cell culture and under subcutaneous whole animal BLI conditions where very little
light is produced due to attenuation of the bioluminescent signal by absorption
from endogenous chromophores (Vo-Dinh 2003). It has been demonstrated here
that cells co-transfected with the codon-optimized luxCDEfrp genes can produce
a lasting signal that can be amplified over integration times as long as 30 min
with little to no background to interfere with signal acquisition (Figure 8F) in a cell
culture setting. However, it is important to note that the bioluminescent signal
from this reaction is produced at 490 nm. This is relatively blue-shifted as
compared to the Luc-based bioluminescent probes that display their peak
luminescent signal at 560 nm. The shorter wavelength of the lux-based signal
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has a greater chance of becoming attenuated within the tissue and therefore may
not be as easily detected if it is used in deeper tissue applications (such as
intraperitoneal or intraorganeller injections), and may require longer integration
times to achieve the same level of detection as a longer wavelength reporter
would when injected subcutaneously. For instance, it has been reported that a
single cell expressing Luc can be detected following subcutaneous injection
(Kim, Urban et al. 2010), whereas it is now demonstrated that the approximate
lower level of detection for lux-tagged cells is closer to 25,000 cells, most likely
due to the lower quantum efficiency of the lux bioluminescent system coupled
with the higher rates of attenuation due to absorption at the emission wavelength
of 490 nm. Therefore, the goals of a particular experiment should be carefully
weighed before applying a lux-based bioluminescent reporter. While a lux-based
system can produce a continuous bioluminescent signal over prolonged time
periods without being subjected to the dynamic effects of repeated luciferin
injections, it may not be appropriate for situations with high levels of signal
attenuation due to its lower emission wavelength.
Despite such drawbacks, the use of cells expressing bacterial luciferase
genes as a probe for whole animal BLI solves many of the problems associated
with the currently available luciferase-based imaging systems. Previous work
with lux genes isolated from P. luminescens has demonstrated that the luciferase
is thermostable at the 37°C temperature required for mammalian imaging
experiments (Colepicolo, Cho et al. 1989). This prevents the associated loss of
signal associated with the short half-life of the firefly luciferase, which has been
70

shown to be thermolabile at 37°C in its native state (Baggett, Roy et al. 2004). In
addition, the autonomous nature of bioluminescent production associated with
the lux system circumvents continuous re-injection of the test animal with an
exogenous luciferin substrate. This simultaneously reduces the amount of
invasive injections required for imaging experiments, eliminates the detection of
artificial results stemming from any non-specific biological reactions with the
luciferin compound being administered, and negates the inability to compare
otherwise similar experiments due to differential bioluminescent production
kinetics based on dissimilar routes of substrate injection. Thus, the bacterial
luciferase offers a more specific, longer lasting, and more humane luciferasebased reporter system than the currently available alternatives.
While mammalian-adapted bacterial luciferase gene expression has some
notable disadvantages such as requisite introduction of multiple gene sequences
and bioluminescent production at a wavelength that is relatively highly absorbed
in mammalian tissues, it remains easily detectable using currently available
imaging technology and offers several important advantages over the currently
available reporter systems for prolonged expression without the cost or
disturbance to the system associated with substrate administration. It is shown
here that expression of the luxCDEfrp genes in mammalian cells can produce the
requisite co-substrates for bioluminescent production and that codon optimization
of these genes improves their performance - leading to an overall increase in
light production as compared to their wild-type counterparts. When co-expressed
with the luxAB genes responsible for formation of the luciferase heterodimer,
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aldehyde production occurs at a level capable of inducing autonomous light
production, but not of high enough concentration to be adversely cytotoxic.
When cells containing full complements of lux genes are enlisted as probes in
whole animal BLI, they are easily detectable when introduced at levels
comparable to cells expressing other currently employed target luciferase genes
and allow for facile differentiation from background over prolonged integration
times at 37°C, making them ideal reporter systems for cell culture, subcutaneous,
or other low absorption environments that require prolonged, real-time monitoring
without disruption.
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CHAPTER III
Comparison Of Mammalian-Adapted Bacterial Bioluminescence
With Firefly Luciferase Bioluminescence And Fluorescence
From The Green Fluorescent Protein

Introduction
Previously it has been demonstrated that autonomous bioluminescent
production from a mammalian cell line expressing human-optimized (ho)
bacterial luciferase (lux) cassette genes can be used as a target for cell culture
and small animal bioluminescent imaging (BLI) (Close, Patterson et al. 2010).
Here the bioluminescent expression of a mammalian HEK293 cell line
transfected with the holux genes is compared with the bioluminescent expression
of the same cell line expressing a commercially available, ho-firefly luciferase
gene (luc) and the fluorescent expression of a commercially available, improved
green fluorescent protein (GFP). The luc and gfp genes are two of the most
widely known and used reporter genes for optical imaging (Choy, O Connor et al.
2003) and therefore provide excellent points of comparison for determining if
holux expression would be beneficial in a given experiment.
The three systems are intrinsically different, and as such, have the potential
to fulfill alternative niches within the needs of the bioimaging community. The
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holux system is unique among bioluminescent systems because of its ability to
self-synthesize and/or scavenge all required substrates from the host cell in order
to produce bioluminescence in a fully autonomous fashion. The system itself is
composed of five genes with the luxA and luxB gene products forming the
heterodimeric luciferase enzyme, and the luxD, luxC and luxE gene products
forming a transferase, a synthase, and a reductase respectfully, that work
together to produce and regenerate the required myristyl aldehyde co-substrate
from endogenous myristyl groups. A sixth gene, frp, encodes an NAD(P)H:flavin
reductase that helps to cycle endogenous FMN into the required FMNH2 cosubstrate. Along with molecular oxygen, these components supply the enzyme
with all the required substrates to produce a bioluminescent signal at 490 nm
(Meighen 1991).
The Luc system catalyzes the oxidation of reduced luciferin in the presence
of ATP-Mg2+ and oxygen to generate CO2, AMP, PPi, oxyluciferin, and yellowgreen light at a wavelength of 562 nm. This reaction was originally reported to
occur with a quantum yield of 0.88 (Seliger and McElroy 1960), but has since
been shown to actually achieve a quantum yield closer to only 0.41 (Ando, Niwa
et al. 2007). The Luc system used in these experiments utilizes a commercially
available holuc gene from the Promega Corporation (luc2). This gene encodes
for an altered protein that improves translational efficiency in the mammalian
cellular background and has also been destabilized to promote lower background
and increased induction levels (Promega 2009).
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The GFP system is perhaps one of the most well characterized and longest
studied of any reporter system available (Wang, John et al. 2008). It differs from
the holux and Luc systems in that it is a fluorescent reporter. Upon excitation at
395 or 478 nm it produces a fluorescent emission signal at 507 nm, allowing for
detection. These experiments use an improved gfp gene that is commercially
available from Invitrogen. This version of gfp has been optimized for higher
levels of solubility and greater than 40-fold increase in fluorescent yield over the
wild-type GFP protein (Crameri, Whitehorn et al. 1996). Despite these
engineered improvements, the requisite excitation signal for this, like the majority
of GFP-variants, elicits high levels of background fluorescence under small
animal imaging conditions (Choy, O Connor et al. 2003; Troy, Jekic-McMullen et
al. 2004). As such, its use in small animal imaging is becoming increasingly
supplanted by proteins or dyes that emit light in the near infrared range where
autofluorescence and absorption levels are lower (Hilderbrand and Weissleder
2009), although its use in the literature is still common and its classical
dominance in the optical imaging field makes it an excellent benchmark for
comparison.
The Luc and GFP imaging targets are representative of the types of reporter
systems commonly employed in the optical imaging community (Burdette 2008),
and provide well known benchmarks against which to compare the
bioluminescent expression of the new holux system. Here the luminescent
profile and intensity of holux expressing HEK293 cells is compared with the
luminescent and fluorescent profiles and intensities of HEK293 cells expressing
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the human optimized Luc and improved GFP systems in cell culture and small
animal imaging conditions. The shape and duration of the resulting light signals
over time are compared, as are respective signal intensities and minimum
detectable reporter cell numbers to establish which type of reporter system may
be most appropriate under a given set of imaging conditions.

Materials And Methods
Strain maintenance and growth
Escherichia coli cells were routinely grown in Luria Bertani (LB) broth with
continuous shaking (200 rpm) at 37°C. When required, kanamycin or ampicillin
was used at final concentrations of 40 and 100 µg/ml, respectfully, for selection
of plasmid containing cells. Mammalian cell lines were propagated in Eagle’s
modified essential medium (EMEM) supplemented with 10% fetal bovine serum,
0.01 mM non-essential amino acids, and 0.01 mM sodium pyruvate. Cell growth
was carried out at 37°C in a 5% CO2 environment and cells were passaged every
3 - 4 d upon reaching 80% confluence. Neomycin and/or zeocin were used for
selection of transfected cells at concentrations of 500 µg/ml and 200 µg/ml,
respectfully, as determined by kill curve analysis, for each antibiotic.
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Development of constitutively active stable cell lines
Transfection

Transfection was carried out in six-well Falcon tissue culture plates (ThermoFisher). HEK293 cells were passaged into each well at a concentration of ~4 ×
105 cells/well in complete medium the day before transfection. Plasmid vectors
were purified from 100 ml overnight cultures of E. coli using the Wizard
Purefection plasmid purification system (Promega). On the day of transfection,
cell medium was removed and replaced and vector DNA was introduced using
Lipofectamine 2000 (Invitrogen).
Selection of stable cell lines

Twenty-four h post-transfection, the medium was removed and replaced
with complete medium supplemented with the appropriate antibiotic. Selection of
successfully transfected clones was performed by refreshing selective medium
every 4 – 5 d until all untransfected cells had died. At this time, colonies of
transfected cells were removed by scraping, transferred to individual 25 cm2 cell
culture flasks, and grown in complete medium supplemented with the appropriate
antibiotics.
Screening of firefly luciferase containing HEK293 cell lines

Following stable selection with antibiotics, cells containing the luc2 gene
were tested to preferentially isolate lines producing the greatest luminescent
signal following addition of D-luciferin. Cells were passaged from individual 25
cm2 culture flasks (Corning) to individual wells of an optically clear 24-well culture
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plate (Costar) and grown until confluence (1 – 2 d). Upon reaching confluence
cells were lysed by application of 1X lysis buffer (Stratagene). Plates were then
transferred to a Synergy 2 microplate reader (BioTek) and luminescence was
measured following addition of 100 µl substrate-assay buffer (Stratagene) using
an 8 sec delay and 10 sec integration time. The cell line producing the greatest
luminescent output during testing was selected and maintained for experimental
use.
Screening of GFP containing HEK293 cell lines

Following stable selection with antibiotics, cells containing the gfp gene
were tested to preferentially isolate the line producing the greatest fluorescent
output signal upon excitation. Cells were passaged from individual 25 cm2
culture flasks (Corning) into black 24-well culture flasks (Costar) in a 2 ml volume
of PBS. Immediately following passage cells were assayed for fluorescent
production in a Wallac 1420 Multilabel counter (Perkin Elmer) using an excitation
wavelength of 485 nm and a 510 nm emission filter. Cells lines producing the
highest levels of fluorescence under these conditions were then subjected to a
second round of testing. In the second stage, cells stably expressing GFP were
grown to confluence in 25 cm2 culture flasks (Corning) and harvested by
trypination. Cell counts were obtained as the average of two counts using a
hemocytometer and cells were plated into black 24-well culture plates (Costar) at
a concentration of ~1 × 106 cells/well in a 1 ml volume of PBS. Cells were then
assayed for fluoresce in an IVIS Lumina in vivo imaging system (Caliper Life

78

Sciences) using the GFP filter set and a 1 sec integration time. The cell line
displaying the highest fluorescent emission signal under these conditions was
selected and maintained for experimental use.
Bioluminescent measurement of bacterial luciferase expressing HEK293
cells in culture
Dynamics of bioluminescent production over time

Actively growing HEK293 cells expressing pLuxCDEfrp:CO/pLuxAB (holux)
were trypsinized and harvested from 75 cm2 tissue culture flasks (Corning) and
viable cell counts were determined as the average of two counts using a
hemocytometer. Approximately 1 × 106 cells per well were plated in each of
three wells in opaque 24-well tissue culture plates (Costar) in DMEM without
phenol red and supplemented with 10% fetal bovine serum, 0.01 mM nonessential amino acids, and 0.01 mM sodium pyruvate. Along with the transfected
cells, an equal number of untransfected HEK293 cells were plated to determine
background luminescent detection levels. Photon counts were recorded using an
IVIS Lumina in vivo imaging system and analyzed with Living Image 3.0 software
(Caliper Life Sciences). The change in light output over time was determined in
photons (p)/sec/cm2/steridian (sr) for each well using integration times of 10 min
and reported as the average of three runs with the standard error of the mean.
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Minimum detectable population size

To determine the minimum detectable population size, serial dilutions of
cells ranging from ~1 × 106 cells per well to ~100 cells per well were plated in
each of three wells in opaque 24-well tissue culture plates in DMEM without
phenol red and supplemented with 10% fetal bovine serum, 0.01 mM nonessential amino acids, and 0.01 mM sodium pyruvate. Along with the transfected
cells, an equal number of untransfected HEK293 cells were plated to determine
background luminescent detection levels. Photon counts were recorded using an
IVIS Lumina in vivo imaging system and analyzed with Living Image 3.0 software
(Caliper Life Sciences). Average radiance for all population sizes was
determined in photons (p)/sec/cm2/steridian (sr) for each well using an integration
time of 10 min 17 h post-plating, as this was shown to be the period of maximum
bioluminescent production as determined by tracking the dynamics of
bioluminescent output as described above. Following initial analysis, a more
specific minimum detectable population size was determined by performing a
second assay using cell concentrations ranging between the lowest detectable
number of the initial assay and the highest undetectable number of cells plated
and comparing the average radiance of each population to the level of
background light detected over cell-free medium. For all measurements,
statistical differences were determined by using Student’s t tests with a p value
cutoff of p = 0.05.
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Bioluminescent measurement of firefly luciferase expressing HEK293 cells
in culture
Dynamics of bioluminescent production over time

Actively growing HEK293 cells expressing pGL4.50[luc2/CMV/Hygro]
(Luc) were trypsinized and harvested from 75 cm2 tissue culture flasks (Corning)
and viable cell counts were determined as the average of two counts using a
hemocytometer. Approximately 1 × 106 cells per well were plated in each of
three wells in opaque 24-well tissue culture plates (Costar) in DMEM without
phenol red and supplemented with 10% fetal bovine serum, 0.01 mM nonessential amino acids, and 0.01 mM sodium pyruvate. Along with the transfected
cells, an equal number of untransfected HEK293 cells were plated to determine
background luminescent detection levels. Immediately prior to imaging, all wells
were spiked with 0.07 mg D-luciferin/ml (Caliper Life Sciences). Photon counts
were then recorded using an IVIS Lumina in vivo imaging system and analyzed
with Living Image 3.0 software (Caliper Life Sciences). The change in light
output over time was determined in photons (p)/sec/cm2/steridian (sr) for each
well using integration times of 10 sec and reported as the average of three runs
with the standard error of the mean.
Minimum detectable population size

To determine the minimum detectable population size, serial dilutions of
cells ranging from ~1 × 106 cells per well to ~100 cells per well were plated in
each of three wells in opaque 24-well tissue culture plates in DMEM without
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phenol red and supplemented with 10% fetal bovine serum, 0.01 mM nonessential amino acids, and 0.01 mM sodium pyruvate. Along with the transfected
cells, an equal number of untransfected HEK293 cells were plated to determine
background luminescent detection levels. Immediately prior to imaging, all wells
were spiked with 0.07 mg D-luciferin/ml (Caliper Life Sciences). Photon counts
were then recorded using an IVIS Lumina in vivo imaging system and analyzed
with Living Image 3.0 software (Caliper Life Sciences). Average radiance for all
population sizes was determined in photons (p)/sec/cm2/steridian (sr) for each
well using an integration time of 10 sec immediately following the addition of
luciferin, as this was shown to be the point of maximal bioluminescent output as
determined by tracking the change in bioluminescent production dynamics as
described above. Following initial analysis, a more specific minimum detectable
population size was determined by performing a second assay using cell
concentrations ranging between the lowest detectable number of the initial assay
and the highest undetectable number of cells plated and comparing the average
radiance of each population to the level of background light detected over cellfree medium. For all measurements, statistical differences were determined by
using Student’s t tests with a p value cutoff of p = 0.05.
Fluorescent measurement of GFP expressing HEK293 cells in culture
Dynamics of bioluminescent production over time

Actively growing HEK293 cells expressing pCDNA3.1-CT-GFP (GFP)
were trypsinized and harvested from 75 cm2 tissue culture flasks (Corning) and
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viable cell counts were determined as the average of two counts using a
hemocytometer. Approximately 1 × 106 cells per well were plated in each of
three wells in opaque 24-well tissue culture plates (Costar) in either DMEM
without phenol red and supplemented with 10% fetal bovine serum, 0.01 mM
non-essential amino acids, and 0.01 mM sodium pyruvate or in PBS. Regardless
of the assay medium, an equal number of untransfected HEK293 cells were
plated to determine background fluorescent production levels upon addition of
the excitation signal. Cells were stimulated in an IVIS Lumina in vivo imaging
system using the supplied GFP excitation filter and photon counts were recorded
using the supplied GFP emission filter. The resulting photon counts were
analyzed with Living Image 3.0 software (Caliper Life Sciences). The change in
fluorescent output over time was determined in photons (p)/sec/cm2/steridian (sr)
for each well using integration times of 1 sec and reported as the average of
three runs with the standard error of the mean.
Minimum detectable population size

To determine the minimum detectable population size, serial dilutions of
cells ranging from ~1 × 106 cells per well to ~100 cells per well were plated in
each of three wells in opaque 24-well tissue culture plates in either DMEM
without phenol red and supplemented with 10% fetal bovine serum, 0.01 mM
non-essential amino acids, and 0.01 mM sodium pyruvate or in PBS. Regardless
of the assay medium, an equal number of untransfected HEK293 cells were
plated to determine background luminescent detection levels. Twenty-four h post
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plating, cells were stimulated in an IVIS Lumina in vivo imaging system using the
supplied GFP excitation filter and photon counts were recorded using a 1 sec
integration time with the supplied GFP emission filter. Twenty-four h post plating
was chosen as this was determined to be the point of highest fluorescent
radiance as determined by tracking the change in fluorescent production over
time as described above. The resulting photon counts were analyzed with Living
Image 3.0 software (Caliper Life Sciences) and recorded as photons
(p)/sec/cm2/steridian (sr) for each well. All reported values represent the average
of three runs with the standard error of the mean. For all measurements,
statistical differences were determined by using Student’s t tests with a p value
cutoff of p = 0.05.
Bioluminescent measurement of bacterial luciferase expressing HEK293
cells in a small animal model system
Ethics statement

All animal work was performed in adherence to the institutional guidelines put
forth by the animal care and use committee of the University of Tennessee. All
animal research procedures were approved by the University of Tennessee
Animal Care and Use Committee (protocol number 1411) and were in
accordance with National Institutes of Health guidelines.
Preparation of cells for injection

Actively growing HEK293 cells expressing pLuxCDEfrp:CO/pLuxAB (lux)
were trypsinized and harvested from 225 cm2 tissue culture flasks and counted
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using a hemocytometer. Using the average of two counts with the
hemocytometer, cells were resuspended at approximately 5 × 106 cells / 100 µl
PBS in a 1.5 ml tube (Eppendorf) for subcutaneous injection or at approximately
1 × 107 cells / 100 µl PBS in a 1.5 ml tube (Eppendorf) for intraperitoneal
injection. Following resuspension, cells were maintained at 37°C in a water bath
until required for injection.
Subcutaneous injection

Five week old nu/nu (nude) mice (NCRNU-M, Taconic Farms Inc.) were
anesthetized via isoflurane inhalation until unconscious. Subcutaneous injections
of ~5 × 106 HEK293 cells expressing pLuxCDEfrp:CO/pLuxAB (lux) in 100 µl
volumes of PBS were performed in both the shoulder and hip of each subject (n
= 3) for a total of n = 6 subcutaneous injections. Due to the of the lack of
endogenous bioluminescent processes in mammalian tissue, and to control for
changes in overall animal size and dispersion of reporter-tagged cells following
injection, readings were gathered as total flux values and presented in photons
(p)/second (s). All subjects were imaged immediately following the injections
using 1 min integration times. Total flux from each injection site was determined
by drawing regions of interest (ROI) of identical size over each location.
Readings were recorded once every 10 min over a 60 min period to determine
the change in flux over time.
To determine the minimal detectable number of cells in vivo, a subject was
subcutaneously injected at three locations - the scruff of the neck, the mid back,
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and hip – with the relevant range of cells as determined by the previously
described minimum detectable cell number assays under culture conditions. All
cell concentrations were injected in a 100 µl volume of PBS. The subject was
then imaged using integration times of up to 10 min to determine if a luminescent
signal could be detected above background at the injected concentrations of
cells. For all measurements, statistical differences were determined by using
Student’s t tests with a p value cutoff of p = 0.05.
Intraperitoneal injection

To measure bioluminescent flux following intraperitoneal injection of the
lux cell line, five week old nu/nu (nude) mice (NCRNU-M, Taconic Farms Inc.)
were anesthetized via isoflurane inhalation until unconscious and each subject (n
= 2) then received a single injection of ~1 × 107 HEK293 cells expressing
pLuxCDEfrp:CO/pLuxAB (lux) in a 100 µ1 volume of PBS. All subjects were
imaged immediately following the injections using 1 min integration times. Total
flux from each injection site, measured as p/s, was determined by drawing
regions of interest (ROI) of identical size over each location. Readings were
recorded once every 10 min over a 60 min period in order to determine the
change in flux over time.
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Bioluminescent measurement of firefly luciferase expressing HEK293 cells
in a small animal model system
Preparation of cells for injection

Actively growing HEK293 cells expressing luc2 (Luc) were trypsinized and
harvested from 225 cm2 tissue culture flasks and counted using a
hemocytometer. Using the average of two counts with the hemocytometer, cells
were resuspended at approximately 5 × 105 cells / 100 µl PBS in a 1.5 ml tube
(Eppendorf) for subcutaneous injection or at approximately 1 × 106 cells / 100 µl
PBS in a 1.5 ml tube (Eppendorf) for intraperitoneal injection. Following
resuspension, cells were maintained at 37°C in a water bath until required for
injection.
Subcutaneous injection

Five week old nu/nu (nude) mice (NCRNU-M, Taconic Farms Inc.) were
anesthetized via isoflurane inhalation until unconscious. Subcutaneous injections
of ~5 × 105 HEK293 cells expressing luc2 (Luc) in 100 µl volumes of PBS were
performed in both the shoulder and hip of each subject (n = 3) for a total of n = 6
subcutaneous injections. Due to the of the lack of endogenous bioluminescent
processes in mammalian tissue, and to control for changes in overall animal size
and dispersion of reporter-tagged cells following injection, readings were
gathered as total flux values and presented in photons (p)/second (s). Following
subcutaneous injection of the reporter cells, each subject was subjected to
intraperitoneal injection of 150 mg D-luciferin/kg and then imaged immediately
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using 1 sec integration times. Total flux from each injection site was determined
by drawing regions of interest (ROI) of identical size over each location.
Readings were recorded once every 10 min over a 60 min period to determine
the change in flux over time.
To determine the minimal detectable number of cells in vivo, a subject was
subcutaneously injected at three locations - the scruff of the neck, the mid back,
and hip – with the relevant range of cells as determined by the previously
described minimum detectable cell number assays under culture conditions. All
cell concentrations were injected in a 100 µl volume of PBS. Prior to imaging,
the subject was intraperitoneally injected with 150 mg D-luciferin/kg. The subject
was then imaged using integration times of up to 10 min to determine if a
luminescent signal could be detected above background at the injected
concentrations of cells. For all measurements, statistical differences were
determined by using Student’s t tests with a p value cutoff of p = 0.05.
Intraperitoneal injection

To measure bioluminescent flux following intraperitoneal injection of the
Luc cell line, five week old nu/nu (nude) mice (NCRNU-M, Taconic Farms Inc.)
were anesthetized via isoflurane inhalation until unconscious and each subject (n
= 2) then received a single injection of ~1 × 107 HEK293 cells expressing luc2
(Luc) in a 100 µl volume of PBS. Following injection of the reporter cell line, all
subjects were injected at the same location with 150 mg D-luciferin/kg and then
imaged immediately following the injections using 10 sec integration times. Total
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flux from each injection site, measured as p/s, was determined by drawing
regions of interest (ROI) of identical size over each location. Readings were
recorded once every 10 min over a 60 min period in order to determine the
change in flux over time.
Fluorescent measurement of GFP expressing HEK293 cells in a small
animal model system
Preparation of cells for injection

Actively growing HEK293 cells expressing gfp (GFP) were trypsinized and
harvested from 225 cm2 tissue culture flasks and counted using a
hemocytometer. Using the average of two counts with the hemocytometer, cells
were resuspended at approximately 5 × 106 cells / 100 µl PBS in a 1.5 ml tube
(Eppendorf) for subcutaneous injection or at approximately 1 × 107 cells / 100 µl
PBS in a 1.5 ml tube (Eppendorf) for intraperitoneal injection. Following
resuspension, cells were maintained at 37°C in a water bath until required for
injection.
Subcutaneous injection

Five week old nu/nu (nude) mice (NCRNU-M, Taconic Farms Inc.) were
anesthetized via isoflurane inhalation until unconscious. Subcutaneous injections
of ~5 × 106 HEK293 cells expressing gfp (GFP) in 100 µl volumes of PBS were
performed in both the shoulder and hip of each subject (n = 3) for a total of n = 6
subcutaneous injections. Subjects were imaged immediately following injection
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with the reporter cell line using GFP excitation and emission filter with an
integration time of 1 sec. Total flux from each injection site was determined by
drawing regions of interest (ROI) of identical size over each location. Readings
were recorded once every 10 min over a 60 min period to determine the change
in flux over time.
To determine the minimal detectable number of cells in vivo, a subject was
subcutaneously injected at three locations - the scruff of the neck, the mid back,
and hip – with the relevant range of cells as determined by the previously
described minimum detectable cell number assays under culture conditions. All
cell concentrations were injected in a 100 µl volume of PBS. The subject was
then imaged using integration times ranging from 0.5 sec to 3 min to determine if
a fluorescent signal could be detected above background at the injected
concentrations of cells. For all measurements, statistical differences were
determined by using Student’s t tests with a p value cutoff of p = 0.05.
Intraperitoneal injection

To measure fluorescent flux following intraperitoneal injection of the Luc
cell line, five week old nu/nu (nude) mice (NCRNU-M, Taconic Farms Inc.) were
anesthetized via isoflurane inhalation until unconscious and each subject (n = 2)
then received a single injection of ~1 × 107 HEK293 cells expressing gfp (GFP) in
a 100 µl volume of PBS. Total flux from each injection site, measured as p/s,
was determined by drawing regions of interest (ROI) of identical size over each
location following a 1 sec integration under GFP excitation and emission filters in
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the IVIS Lumina in vivo imaging system (Caliper Life Sciences). Readings were
recorded once every 10 min over a 60 min period in order to determine the
change in flux over time.

Results
Bioluminescent measurement of bacterial luciferase expressing HEK293
cells in culture
Minimum detectable population size

Cells expressing the holux cassette genes produced a visible light signal
over a range from approximately 1 × 106 cells/well to 1.5 × 104 cells/well using a
10 min integration time (Figure 10A). A detectable light signal was inconsistently
observed at a concentration of ~1 × 104 cells/well, however this was determined
not to be significantly distinguishable from background (p = 0.72) (Figure 11). In
general, detection of lower cell populations as significantly different than
background was more feasible at time points further from the initial plating (Table
4).
Dynamics of bioluminescent production over time

The luminescent profile of holux expression demonstrated a consistent
increase in average radiance from an initial post-plating value of 1,800 p/s/cm2/sr
to a peak of 6,400 p/s/cm2/sr 16 h post-plating (Figure 10B). Following peak
bioluminescence, the cells expressed a slow decrease in average radiance over
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Figure 10. Comparison of in vitro imaging results.
Pseudocolor representation of the bioluminescent or fluorescent flux from cell concentrations
ranging from 1 million (1M) to several thousand (K) to approximately single cell levels (NEG =
negative control wells) stably transfected with (A) holux, (C) Luc, or (E) GFP. Red lines indicate
the combination of two separate runs, each represented by the corresponding color scale on the
right or left side of the figure. The yellow box in (E) indicates wells containing equal numbers of
untransfected HEK293 cells to determine levels of background autofluorescence. Note that
autoscaling of the pseudocolor image assigns brighter colors and larger areas to the larger
population sizes of low level detection experiments although their scale indicates overall lower
levels of flux compared to larger population sizes. Average bioluminescent or fluorescent flux
6
dynamics for the (B) holux, (D) Luc, and (F) GFP containing cell populations of ~1 × 10 cells over
a 24 h period demonstrate the differences in signal intensity over time.
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Figure 11. Detection of 10,000 lux-tagged HEK293 cells was not possible at statistically
significant levels.
Despite presenting an intermittently detectable pseudocolor image, a population of ~10,000 holux
expressing cells could not be statistically differentiated from background light detection. Boxes
represent the mean values of three trials, reported with overlapping standard error of the means.
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Table 4. Detection of lux-expressing HEK293 cells over time.
Larger population sizes of lux-expressing cells were visible sooner following plating. Green boxes represent time points where the
indicated cell population was significantly distinguishabe from background. Red hatched boxes represent time points where the indicated
cell population was not significantly distinguishable from background light detection.
Lux
Time Post Plating (h)
Cell Population
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Size
15K Cells/well
20K Cells/well
30K Cells/well
50K Cells/well
75K Cells/well
100K Cells/well
1M Cells/well
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the remainder of the 24 hr assay, averaging a reduction of 135 (± 16) p/s/cm2/sr
per hr. Expression was consistent over the course of the assay with the standard
error of the mean averaging 58 (± 4) p/s/cm2/sr at each time point surveyed.
Bioluminescent measurement of firefly luciferase expressing HEK293 cells
in culture
Dynamics of bioluminescent production over time

The luminescent profile of the Luc expressing cells displayed a large initial
intensity, with a peak average radiance of 8.9 (± 0.4) × 107 p/s/cm2/sr 10 min
following addition of 0.07 mg D-luciferin/ml. This level of radiance was not
maintained, however, and had decreased to 3.0 (± 0.3) × 107 p/s/cm2/sr by 40
min post addition. The decrease in radiance occurred during the period 10 to 30
min post substrate addition, after which the signal remained steady (± 9.3 × 105
p/s/cm2/sr) for the remainder of the assay. Concurrent with the higher
bioluminescent output of the Luc expressing cells compared to holux was a
larger standard error. The average error over the course of the Luc
luminescence assay was 2.9 (± 0.6) × 106 p/s/cm2/sr (Figure 10D).
Minimum detectable population size

Cells expressing the human-optimized luc2 gene displayed a significantly
greater average radiance (p < 0.01) than those expressing the human-optimized
lux genes and as a result were visible at lower concentrations. Luc expressing
cells produced a visible signal over a range from ~1 × 106 cells/well down to 250
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cells/well at an integration time of 1 sec (Figure 10C and Figure 12A). Although
concentrations as low as 50 cells/well could be differentiated from background if
the integration time was extended to 10 sec (Figure 12B), this concentration of
cells was not determined to be statistically greater than background light
detection (p = 0.65) while using the 1 sec integration time required to prevent
saturation of the camera at the higher cell concentrations (Figure 12A).
Detection of the Luc-tagged cell populations showed the opposite trend of those
expressing the holux genes and was generally easier to differentiate from
background at time points closer to luciferin addition (Table 5).
Fluorescent measurement of GFP expressing HEK293 cells in culture
in cell culture medium

When HEK293 cells expressing GFP were tested in DMEM without phenol
red it was not possible to detect the fluorescent signal of the cells above the
background level of fluorescent detection at any of the population sizes
surveyed. In order to better differentiate the target signal from background, the
integration time was lowered down to a minimum of 0.5 sec, however this had no
effect on the ability to distinguish signal from noise. Based on these results it
was concluded that the assay would be preformed in PBS, as this media did not
contain any serum proteins or compounds to contribute to the production of nonspecific background signal in the presence of the GFP excitation signal.
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Figure 12. Minimum population size detection of Luc-tagged HEK293 cells.
Short integration times (~1 sec) are required to prevent saturation of the CCD camera when using
a Luc-based reporter system due to its high levels of bioluminescent flux following D-luciferin
amendment. However, at integration times of 1 sec (A) it is not possible to differentiate Lucexpressing cell populations below ~250 cells from background light detection. Increasing the
integration time to ~10 sec (B) in the absence of larger population sizes to prevent camera
saturation allows for detection down to ~50 cells. Boxes represent the mean values of three
trials, reported with the standard error of the mean.
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Table 5. Detection of Luc-expressing HEK293 cells over time.
Larger populations of Luc-expressing cells were visible over longer periods of time following the addition of D-luciferin. Due to the highly dynamic
nature of Luc expression, readings are reported at 10 min intervals. Green boxes represent time points where the indicated cell population was
significantly distinguishable from background. Red hatched boxes represent time points where the indicated cell population was not significantly
distinguishable from background light detection.
Time Post Luciferin Amendment (min)
0

10

20

30

40

50

60

70

80

90

100

110

120

130

350

360

370

380

390

400

410

420

430

440

450

460

470

480

700

710

720

730

740

750

760

770

780

790

800

810

820

830

140

150

160

170

180

190

200

210

220

230

240

250

260

270

280

290

300

310

320

330

340

570

580

590

600

610

620

630

640

650

660

670

680

690

920

930

940

950

960

970

980

990

1000

1010

1020

Cells/Well

1
50
100
250
500

Time Post Luciferin Amendment (min)
490

500

510

520

530

540

550

560

Cells/Well

1
50
100
250
500

Time Post Luciferin Amendment (min)
840

850

860

Cells/Well

1
50
100
250
500
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870

880

890

900

910

1030

In phosphate buffered saline

Dynamics of bioluminescent production over time
Average radiance of HEK293 cells stably expressing GFP in a PBS as a
medium increased slightly but not significantly (p = 0.08) over the course of the
assay from an initial value of 6.0 (± 0.06) × 106 p/s/cm2/sr to a peak of 6.6 (±
0.07) × 106 p/s/cm2/sr by 22 h after the initial plating. Over the full course of the
assay the average radiance remained relatively steady at 6.2 (± 0.05) × 106
p/s/cm2/sr with an average error of 7.3 (± 0.3) × 104 p/s/cm2/sr (Figure 10F).
Minimum detectable population size
Fluorescent detection from GFP emission presented the least sensitive
lower limits of detection for any of the three reporter systems tested when PBS
was used as the assay medium. Under these conditions detection ranged from
~1 × 106 cells/well down to 5 × 105 cells/well (Figure 10E). Although wells of less
than ~5 × 105 cells/well clearly show fluorescent signals, they were not
significantly different from background following subtraction of background tissue
autofluorescence (Figure 13). Similar to the holux-expressing cells, detection
ability increased for the smaller population sizes over the course of the assay
(Table 6). A full comparison of the pertinent expression data for all three reporter
systems is detailed in Table 7.
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Figure 13. Minimum population size detection of GFP-tagged HEK293 cells.
5

Cells expressing GFP were visible down to population sizes of ~5 × 10 cells. Boxes represent
the mean values of three trials, reported with the standard error of the mean.
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Table 6. Detection of GFP-expressing HEK293 cells over time.
GFP-expressing cells could be significantly differentiated from background fluorescence detection at all time points following plating when
5
5
greater than ~5 × 10 cells were present. Detection of ~5 × 10 cells became possible 9 hr after plating, while detection of less than ~5 ×
5
10 cells was not possible at any of the time points surveyed. Green boxes represent time points where the indicated cell population was
able to be significantly distinguishable from background. Red hatched boxes represent time points where the indicated cell population
was not significantly distinguishable from background light detection.
GFP
Time Post Plating (hr)
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Cell Population Size
100 Cells/well
1K Cells/well
10K Cells/well
100K Cells/well
500K Cells/well
750K Cells/well
1M Cells/well
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Table 7. Summary of comparisons between the holux, Luc, and GFP reporter systems
under in vitro and in vivo imaging conditions.

in vitro

Maximum Average
Radiance
(p/s/cm /sr)
6.4 (± 0.1) × 10

Luc
GFP

Radiance
(p/s/cm2/sr)

Radiance (h)
3

Minimum

Range Of Average

Peak
Average

2

holux

Time To

Average Error

Detectable Cell

(p/s/cm2/sr)

Number Across
All Time Points

58 (± 4)

1 × 105

8.9 × 107

2.9 (± 0.6) × 106

250

6.0 × 105

7.3 (± 0.3) × 104

7.5 × 105

16

4.6 × 10

8.8 (± 0.4) × 107

0.17

6.6 (± 0.1) × 106

22

3

in vivo
Subcutaneous
Maximum Total

Number Of

Average Error

Flux

Cells

(p/s)

(p/s)

Integration
Time (sec)

Injected

Minimum
Detectable Cell
Number

holux

1.5 (± 0.2) × 105

1.6 (± 0.3) × 104

5 × 106

60

2.5 × 104

Luc

2.0 (± 0.2) × 108

4.0 (± 0.5) × 107

5 × 105

1

2.5 × 103

Intraperitoneal
Maximum Total Flux

Average Error

(p/s)

(p/s)

holux

3.6 (± 0.2) × 10

Luc

1.6 (± 0.3) × 109

5

7.0 (± 2.2) × 10

3

5.8 (± 2.1) × 107
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Number Of Cells

Integration Time

Injected

(sec)

7

1 × 10

60

1 × 106

10

Bioluminescent measurement of bacterial luciferase expressing HEK293
cells in a small animal model system
Subcutaneous injection

Average flux from subcutaneous injection of ~5 × 106 holux expressing
cells was 1.5 (± 0.2) × 105 p/s and remained relatively constant over the full
course of the 60 min assay, displaying a minimum flux of 1.3 (± 0.1) × 105 p/s
and a maximum of 1.5 (± 0.2) × 105 p/s. The standard errors of the readings
were relatively low, averaging 1.6 (± 0.3) × 104 p/s and therefore provide
readings with increased resolution compared to the Luc reporter system. Over
the full course of the assay, the bioluminescent profile remained relatively flat,
displaying a range of 2.8 × 104 p/s between the lowest and highest recorded
values (Figure 14A). To obtain a representative pseudocolor image during
acquisition, integration times of 1 min were used, however, it was previously
demonstrated that detection following subcutaneous injection of ~5 × 106 holuxexpressing cells is possible using ~30 sec integration times (Close, Patterson et
al. 2010). It was also demonstrated that following subcutaneous injection the
lower level for detection was 25,000 cells when using increased integration times
(~10 min) (Figure 14B).
Intraperitoneal injection

Intraperitoneal injections of ~1 × 107 holux expressing cells yielded a
disparate bioluminescent profile from that of the subcutaneous injections. The
largest total flux was measured immediately following injection at a rate of
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Figure 14. Comparison of in vivo bioluminescence for holux and Luc cells.
The bioluminescent signal following subcutaneous injection of holux-expressing cells (A) remains
relatively stable following injection and is detectable (B) down to a minimum of ~25,000 cells.
Signal dynamics are significantly altered (C), but of approximately the same strength following
intraperitoneal injection. Total flux from subcutaneous injection of Luc-expressing cells (D) is
significantly higher, and as such is detectable (E) down to ~2,500 cells. Bioluminescent output
from intraperitoneal injected Luc-expressing cells (F) expressed peak flux immediately following
D-luciferin injection, but then quickly diminished over the remainder of the assay.
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3.6 (± 0.2) × 105 p/s. Following this initial light output, the total flux continued to
trend downward over the remainder of the assay (Figure 14C). The greatest
decrease, presumably from dispersion of the cells following injection, occurred
during the first 15 min, during which the total flux decreased from the maxima to
2.4 (± 0.2) × 105 p/s. After this time, the rate of bioluminescent production
remained relatively flat, decreasing ~67,000 p/s by the final time point of the 60
min assay. Due to the diffusion of cells within the intraperitoneal cavity following
injection and the increased amount of scattering and absorption associated with
intraperitoneal imaging, pseudocolor images obtained using a 60 sec integration
time were not as well defined as those from the subcutaneous injections despite
the injection of a higher number of cells (Figure 15 A and C). The expression
value differences (in p/s) that lead to these changes in pseudocolor
representation are presented in Table 7.
Bioluminescent measurement of firefly luciferase expressing HEK293 cells
in a small animal model system
Subcutaneous injection

Subcutaneous injection of ~5 × 105 Luc containing cells produced a bell
curve of bioluminescent production. Immediately following intraperitoneal
injection of 150 mg D-luciferin/kg the average total flux from each injection site
was 1.0 (± 0.2) × 106 p/s. Total flux then increased rapidly over the next 40 min
to a maximum of 2.0 (± 0.5) × 108 p/s before declining for the remainder of the 60
min assay. Along with the increased flux values were increased error ranges at
each time point as compared to the holux-expressing cell line. Standard error of
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Figure 15. Comparison of pseudocolor images of subcutaneously and intraperitonealy
injected holux and Luc Cells.
Subcutaneously injected (A) holux or (B) Luc expressing cells are capable of presenting relatively
similar images despite the large differences in total flux from each reporter system if the
integration time is increased from 1 sec (Luc) to 60 sec (holux). Similar increases must be made
to maintain uniform representative detection following intraperitoneal injection of the (C) holux
and (D) Luc cells as well, with the holux system requiring a 60 sec integration time to achieve
similar peudocolor patterning as a 10 sec integration of the Luc system.
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each reading averaged 4.0 (± 0.5) × 107 p/s (Figure 14D). Visual detection of
signal was never problematic, with a 1 sec integration providing ample exposure
for facile visual representation of the subcutaneous injection site (Figure 15B).
With the system under the control of the CMV promoter, the minimum detectable
cell number was determined to be 2,500 under subcutaneous imaging conditions
(Figure 14E).
Intraperitoneal injection

Intraperitoneal injections of ~1 × 106 Luc expressing cells produced a
much different time dependent bioluminescent expression profile than that
obtained following subcutaneous injections (compare Figure 14F to Figure 14D).
The magnitude of bioluminescent flux notwithstanding, the time dependent
bioluminescent profile following intraperitoneal injection of Luc expressing cells
yielded a profile similar to that obtained following intraperitoneal injections of
holux expressing cells (compare Figure 14F to Figure 14C). The highest total
flux occurred immediately after intraperitoneal injection of 150 mg D-luciferin/kg
at 1.6 (± 0.3) × 109 p/s. The bioluminescent flux then quickly decreased to 1.0 (±
0.1) x 109 p/s by 10 min post luciferin injection. For the remaining 50 min of the
assay the total flux remained relatively constant, averaging 9.2 (± 0.2) × 108 p/s.
As with the holux-expressing cells, integration time had to be extended to obtain
a representative visual image of the intraperitoneal injection site. Intraperitoneal
injection of ~1 × 106 Luc-expressing cells, followed by immediate imaging post Dluciferin injection using a 10 sec integration time, produced a pseudocolor visual
107

representation similar to the pseudocolor images obtained using a 60 sec
integration time following injection of ~1 × 107 holux-expressing cells, but did not
produce images that were as well defined as those following subcutaneous
injection (Figure 15 B and D). This is presumably due to the increases in
absorbance and scattering associated with injection into the intraperitoneal
cavity. A summary of the differences between Luc expression in vivo or in vitro
following either a subcutaneous or intraperitoneal injection can be found in Table
7.
Fluorescent measurement of GFP expressing HEK293 cells in a small
animal model system
Subcutaneous injection

Subcutaneous injections ranging from ~1 × 104 to ~1 × 107 GFP
expressing cells failed to produce a detectable fluorescent signal when
expressed in a nude mouse model. When regions of interest were drawn over
the injection site of ~1 × 107 cells in a 100 µl volume of PBS, these locations did
not produce significantly more fluorescent flux then was measured over
background from a region of identical size distal from the injection site (p =
0.739). The location of the injection did not have a statistically detectable effect
on the strength of the resulting fluorescent signal, with injection into the shoulder
or the rump resulting in similar levels of detection for equal numbers of injected
cells (p = 0.050).
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Intraperitoneal injection

Similar to the results obtained following subcutaneous injection,
intraperitoneal injection of GFP expressing cells at population sizes up to ~1 ×
107 were not able to be detected at any time point during the 60 min course of
the assay. Regions of interest of identical size drawn either over the injection
site, or distal from the injection site at an area not expected to display fluorescent
signal displayed similar levels of fluorescent flux across all surveyed time points
(p = 0.100).

Discussion
There have been myriad demonstrations of the bioluminescent and
fluorescent profiles obtained in culture or small animal imaging when employing
the Luc or GFP proteins as targets. The variety and scope of published literature
utilizing these, or versions of these, reporters is testament to their usefulness, as
well as the expression strategies to which they can be adapted within the
confines of a particular experimental design. To aid in the comparison of the
three different systems under conditions that are as uniform and comparable as
could be achieved, each was expressed in the same cellular background
(HEK293) and placed under the control of identical cytomegalovirus (CMV)
promoters. The use of identical promoters should encourage similar levels of
expression when each construct is expressed in the HEK293 cell line (Qin,
Zhang et al. 2010). However, in the holux cell line, although luxAB is driven by
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the CMV promoter, the luxC and luxE genes are instead under the control of the
human elongation factor 1α (EF-1α) promoter. Because the previously published
demonstration of holux function was designed in this manner (Close, Patterson et
al. 2010) it was not subjected to any modification prior to expression in order to
allow for consistent comparison with the previously published results.
As expected, bioluminescence from the Luc system was detectable at lower
cell concentrations and displayed a significantly larger total flux than holuxcontaining cells in the mouse imaging experiments and its detection level was
lower than both the lux and GFP reporters in the cell culture imaging scenarios.
Under conditions where only small populations of Luc-expressing cells were
assayed in cell culture as few as 50 Luc cells/well were visible (Figure 10C and
Figure 12B) compared with a minimum of 15,000 cells/well for the holux system
(Figure 10A) and 500,000 cells/well in the GFP system when cells were imaged
in PBS (Figure 10E and Figure 13). The need to use PBS as a liquid medium to
detect lower GFP-expressing cell numbers due to the autofluorescence from the
cell culture medium represents a crucial problem with using fluorescent systems
for prolonged cell culture imaging. The lack of medium components such as
serum and nutrients required for low-level fluorescent detection does not promote
continued cellular growth, thereby preventing potential autonomous fluorescent
monitoring without regular medium changes. The inclusion of these compounds
can prevent this, but increases the minimum detectable cell number beyond 1
million cells/well, and therefore could not be detected under our imaging
conditions.
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Another approach to overcome the poor sensitivity of GFP in culture is to use
an alternate cell line capable of more efficiently expressing the reporter. It has
previously been demonstrated that GFP expression under the control of the CMV
promoter in the MCF-7 breast cancer cell line is capable of being detected at
lower numbers of GFP expressing cells/well (Caceres, Zhu et al. 2003), however,
these experiments were conducted in wells of significantly smaller surface area
(0.32 cm2 as compared to 1.9 cm2) than used in these experiments. When the
results from both experiments are normalized to media volume, this corresponds
to a lower detection level of ~250 cells/µl using MCF-7 cells compared to ~500
cells/µl when expressed in HEK293 cells.
Our results demonstrate, however, that the use of bioluminescence rather
than fluorescence overcomes this problem completely; however, there is a large
difference in the bioluminescent output levels and imaging strategies between
the holux and Luc systems. The holux system has the advantage of not requiring
addition of a substrate to elicit bioluminescent production, therefore allowing for
completely autonomous bioluminescent readings that should routinely correlate
with cell number, regardless of time. The disadvantage of the holux system is
that it is significantly less efficient than the Luc system. While the average
radiance of ~1 × 106 holux cells had a peak value of 6,400 p/s/cm2/sr, this is
comparable to the peak average radiance of only ~100 HEK-Luc cells/well
(although this number of cells/well cannot be reliably detected following the initial
bioluminescent burst following substrate amendment as shown in Table 5).
Therefore, detection of small numbers of cells in culture is best suited to a Luc111

based reporter system, especially if the production of light is only to be monitored
over short time periods. However, if working with larger cell populations, the use
of a holux-based reporter system gives the benefit of continuous bioluminescent
output, and is not dependent on the addition of luciferin to the cell culture
medium. Regardless of which reporter system is employed, the use of a
bioluminescent system (either holux or Luc) has the advantage of low
background detection when compared with the use of a fluorescent system such
as GFP in a medium-based cell culture setting.
When applied to small animal imaging, the same general benefits for each
reporter system are reiterated. The major disadvantage of working with GFP or
alternate fluorescent reporter systems in an animal model is the relatively high
level of background fluorescence resulting from excitation of endogenous
chromophoric material within the subject tissue. The use of a bioluminescent
reporter helps to overcome this disadvantage due to the low levels of background
autoluminescence in mammalian tissues (Welsh and Kay 2005). While Lucbased systems have most often been utilized for small animal imaging, the holux
system provides a distinct advantage for near-surface target visualization.
Although not as bright as the Luc system (total flux averaged 1.5 (± 0.2) × 105 p/s
for a subcutaneous injection of ~5 × 106 HEK293 holux cells vs. an overall
average total flux of 1.4 (± 0.2) × 108 p/s for a subcutaneous injection of ~5 × 105
Luc cells) the bioluminescent profile of the holux-containing cells was relatively
flat over the full course of the assay, while the bioluminescent profile of the Luccontaining cells varied greatly following substrate injection. In addition, the act of
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luciferin supplementation encompasses its own set of concerns. It has been well
documented that the bioluminescent profile can be altered depending on the
route of substrate administration for Luc-based systems (Inoue, Kiryu et al.
2009), with each route having different uptake rates throughout the body (Lee,
Byun et al. 2003). Also of concern, the process of substrate injection allows for
the introduction of error due to differences in the efficiency of each injection
and/or the possibility of potential injection failure (i.e. injection into the bowel
during intraperitoneal administration) (Inoue, Kiryu et al. 2009). Any changes in
the quality of the luciferin over time during multiple injections (Mohler 2010) as
well as the possible introduction of tissue damage that can prohibit further
injections are also of concern (O'Neill, Lyons et al. 2010). For large-scale
experiments, the cost of luciferin must also be taken into consideration, as it is an
expensive substrate. Therefore, the use of a holux-based reporter is more
simplistic and economical and may provide more reliable results if relatively large
numbers of cells are being imaged close to the surface of the subject.
The inability to detect injections of GFP-expressing HEK293 cells at
concentrations up to ~1 × 107 is in line with what has been previously reported in
the literature. It has been previously demonstrated that HEK293 cells expressing
GFP were not detectable until 7 d post injection when population sizes of 1 × 106
cells were used for injection (Choy, O Connor et al. 2003). With the doubling
time of HEK293 cells reported to be 34 h, these cells should have reached a
population size of ~1 × 107 by ~5 days, two full days prior to when they were first
reported to be detectable. When GFP is expressed in other cell lines, however,
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the time until detection can change. It has been reported that injection of ~1 ×
107 GFP expressing MCF-7 cells was possible 1 d following injection (Caceres,
Zhu et al. 2003), however, no information was given as to the detection ability
immediately following injection. Although it may have been possible to elicit a
detectable fluorescent signal by injection a higher concentration of GFP
expressing cells, injection size was limited to ~1 × 107 cells because this was the
largest injection size commonly reported in the literature.
While previous reports have suggested that detection of a single cell
expressing the luc reporter gene is possible in the 4T1 mouse mammary tumor
line (Kim, Urban et al. 2010), it is shown here that a minimum of 2,500 cells are
required when the Luc system is expressed in HEK293 cells under the control of
a CMV promoter (Figure 14E). Despite the increase in cells required for
detection under our expression conditions, this number was still well below that
required for detection of the holux-expressing cells (Figure 14B). The diminished
performance of the holux cells compared to Luc-containing cells during both
minimal detection level testing and intraperitoneal injection demonstrates that the
associated benefits of the holux system are of little value if they cannot be easily
detected under experimentally relevant imaging conditions. In cases where deep
tissue imaging is required, the use of a Luc-based system can be advantageous
despite the concerns associated with substrate addition, especially since its use
in these types of experiments is widespread and well documented. Whether
subcutaneous or intraperitoneal injection is chosen as the route of administration,
it is important to realize that the decreased efficiency of the holux system as
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compared to the Luc system necessitates an increase in integration time to
obtain similar detection levels (Figure 15). The amount of time required for signal
detection must therefore be considered in the context of a given experiment to
determine if detection of the holux signal at a level similar to what a researcher
may be accustomed to using a Luc-based system is acceptable.
The greatest advantages of the new holux system, however, are the ability
for researchers to integrate its use alongside other established fluorescent and
bioluminescent systems and the ability to exploit the unique autonomous nature
of lux bioluminescent expression with novel detection methods. Because the
presence of fluorescently labeled cells would not be detected under
bioluminescent imaging conditions (i.e. in the absence of an excitation signal),
the location and size of bioluminescent signals could be determined and then
differentiated from any fluorescent signals detected following administration of
the excitation signal. In addition, the holux signal could be determined prior to
substrate injection in conjunction with alternative bioluminescent reporter
systems to sequentially determine the location and size of differentially labeled
cell populations within a living host. Alternatively, the autonomous nature of lux
bioluminescent expression could allow it to be paired with miniaturized integrated
circuit microluminometers (Islam, Vijayaraghavan et al. 2007) that could one day
be implanted under the skin of an animal subject, allowing for real-time detection
of signal without the need for external imaging equipment. This possibility opens
the door for development of integrated biofeedback circuits that can
autonomously monitor and subsequently react to numerous in vivo disease
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conditions. So while the introduction of a holux imaging target certainly does not
displace the use of currently available fluorescent and bioluminescent imaging
targets, it can overcome some of the shortcomings of these systems and
integrates well with them as an additional tool for noninvasive imaging.
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CHAPTER IV
Use Of Mammalian-Adapted Bacterial Luciferase Genes As A
Reporter System For Use In The Mammalian Cellular
Background

Introduction
For many years researchers have been using bacteria and simple
eukaryotes such as yeast to serve as proxies for measuring the bioavailability of
exposed chemicals to human cells. These simple models have distinct
advantages of being easy to manipulate in the laboratory, inexpensive to
maintain, and highly amenable to high throughput experimental design.
However, as attractive as they might be, they are not completely representative
of human derived cells. As such, there is always some amount of caution that
must be taken when interpreting the data obtained using these models and
relating it to human bioavailability. Oftentimes human derived cells cannot be
used for bioavailability screening because of the lack of reporter systems
allowing for real-time, autonomous reporting of the associated effects.
Fluorescent reporter systems can be employed that do not require addition of
potentially influential substrates for signal generation, however, these systems
have high levels of background and can require expensive equipment to properly
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filter their excitation and emission signals (Tsien 1998). The use of currently
available bioluminescent systems can overcome some of these technical hurdles
and allow for inexpensive bench top monitoring, but does so at the cost of
potentially error inducing substrate addition.
The simplest solution to this problem is to work in a less complex model
system such as Escherichia coli or various other traditional prokaryotic
organisms. This is most often done to partially alleviate the cost, scalability, and
narrowed reporter availability issues that have traditionally restricted direct
testing in mammalian cell lines. However, these logistical considerations come
at a cost. Oftentimes the use of a prokaryotic or lower eukaryotic organism
dictates that there will be significant differences in the metabolic pathways and
extracellular receptor profiles as compared to those present when directly testing
in mammalian cells. This has traditionally been a problem when studying the
effects of compounds such as estrogen, which cannot be metabolically
processed by prokaryotic organisms, or attempting to elucidate the intricacies of
organelle formation, which again is not feasible using a bacterium lacking in
these cellular components (Campbell, Reece et al. 2007).
In some cases, such as screening for estrogenic compounds, a lower
eukaryotic host such as Saccharomyces cerevisiae is therefore employed that is
capable of reacting to the presence of the target compound (Sanseverino, Gupta
et al. 2005). However, even when using another eukaryotic organism as a proxy,
there is no way to directly relate the ensuing findings to human bioavailability.
Ultimately, the only way to draw direct comparisons to how a given compound
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will affect a human cell is to directly test it on the tissue of interest. The use of
mammalian cells that can react to the presence of a compound of interest either
through the production or reduction of a bioluminescent signal in a near real-time
fashion would provide a novel method for the detection and evaluation of
biomedically relevant compounds in an efficient and high throughput manner,
filling the niche left by the currently available mammalian-compatible reporter
systems.
These concerns are clearly illustrated in the toxicology field, where it is
estimated that ~$2.7 billion is spent on toxic chemical screening alone, with much
of that sum being directed to animal testing (Hartung 2009). Despite this
expenditure, the use of animal subjects has proven to be a poor substitute for
human exposure. In one classic example, testing using rodents was shown to be
able to correctly identify toxic effects in humans at a rate of only 43% (Olson,
Betton et al. 2000). The use of a high throughput mammalian cell line that can
be used as a screen for compound toxicity could greatly improve upon the
current detection methods, as well as provide a low cost method to determine
which compounds should be studied in greater detail (Ekwall, Silano et al. 1990).
Here the use of human derived HEK293 cells stably transfected with the
luxCDABEfrp genes of the bacterial bioluminescence cassette (lux) is
investigated as a means of overcoming the limitations imposed by currently
available mammalian cell based bioavailability detection methods. To investigate
the utility of these cells to act as biosensors for the presence of a specific target
chemical, a version of the lux gene cassette was created that regulated the
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expression of the luxC and luxE genes in response to doxycycline using the
commercially available TET-On system (Clontech). The TET-On system
represents a common method for evaluating the effectiveness of a reporter
system as it has previously been shown to be effective for expression of a wide
array of reporter genes across multiple mammalian cell lines (Freundlieb 2007)
and therefore allows for the facile comparison of reporter function with previously
published models.
It has previously been demonstrated that bioluminescence can be
detected from small numbers of human cells expressing the lux genes, and that
the bioluminescent flux can be correlated to overall cell population size (Close,
Patterson et al. 2010). This makes the substrate-free, real-time bioluminescent
response of a lux-expressing cell line an excellent platform for development into
a mammalian-based reporter system designed to signal target compound
detection, as well as allowing for it to be developed into a first-of-its-kind
biosentinel for toxic chemical exposure. The latter is made possible because the
persistence of the bioluminescent signal without excitation or addition of
substrate makes it possible to measure changes in overall bioluminescent
production as an indicator for changes in cellular growth and metabolism.
These types of measurements would not be possible using other reporter
systems due to the economic and logistical concerns related to constantly
simulating the reporter protein in order to generate the continuous signal required
for real-time monitoring. The ability to autonomously produce a bioluminescent
signal in response to a specific compound of interest without the requirement of
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investigator intervention allows for the possibility of high throughput, on-line,
remote detection systems that could significantly improve on the cost and
efficiency of current detection methods. In addition, the ability to efficiently
screen multiple compounds in parallel in order to evaluate their potential
cytotoxic effects directly on human cells gives the lux reporter system an
advantage over other fluorescent or bioluminescent reporter systems in the field
of toxicology.

Materials And Methods
Strain maintenance and growth
Escherichia coli cells were routinely grown in Luria Bertani (LB) broth with
continuous shaking (200 rpm) at 37°C. When required, kanamycin or ampicillin
was used at final concentrations of 40 and 100 µg/ml, respectfully, for selection
of plasmid containing cells. Mammalian cell lines were propagated in Eagle’s
modified essential medium (EMEM) supplemented with 10% fetal bovine serum,
0.01 mM non-essential amino acids, and 0.01 mM sodium pyruvate. Cell growth
was carried out at 37°C in a 5% CO2 environment and cells were passaged every
3 - 4 d upon reaching 80% confluence. Neomycin, hygromycin, and/or zeocin
were used for selection of transfected cells at concentrations of 500 µg/ml, 100
µg/ml, or 50 µg/ml, respectfully, as determined by kill curve analysis, for each
antibiotic.
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Cloning of the tetracycline response element
PCR amplification

Primers were designed (TET-forward 5’GCTAGCAGGTGGCGTGTACGGTGGGA-3’, TET-reverse 5’GCGGCCGCTCCAGGCGATCTGACGGTTC-3’) to amplify a 349 bp region of
the pTRE-Tight-BI plasmid (Clontech) containing both the tetracycline response
element and its associated CMV promoter sequence. The TET forward primer
was engineered to contain an NheI restriction site, while the TET reverse primer
was engineered with an associated NotI restriction site. This allowed for the
attainment of an altered PCR product that contained a 5’ NheI restriction site,
followed by the tetracycline response element and CMV promoter, then a 3’ NotI
restriction site. The resulting PCR product was then immediately TOPO cloned
into the pCR4-TOPO vector (Invitrogen) to create pCR4-TET. This plasmid was
used as the basis for allowing propagation and maintenance of the receptor
fragment.
Introduction of the tetracycline response element into pLuxCDEfrp

The tetracycline response element and its associated CMV promoter were
removed from pCR4-TET using the NheI and NotI restriction sites. In parallel
with this reaction, the EF1-α promoter was removed from pLuxCDEfrp using the
same restriction sites. Following restriction digest, both reactions were purified
by gel electrophoresis. The ~350 bp band representing the tetracycline response
element and the CMV promoter were extracted from the lane containing the
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pCR4-TET digestion and the ~8.9 kb band representing the pLuxCDEfrp plasmid
with the EF1-α promoter removed was extracted from the lane containing the
pLuxCDEfrp digestion. Both isolated fragments were purified using QIAquick Gel
Extraction kits (Qiagen). The purified fragments were ligated together for 5 min
at room temperature using T4 DNA polymerase (Promega) in LigaFast buffer
(Promega) to create the plasmid pLuxCDEfrp-TET. The ligated plasmid DNA was
then used directly for transformation. Chemically competent E. coli were
inoculated with 2 µl of the pLuxCDEfrp-TET ligation product and selected by growth
on LB medium containing 100 µg Ampicillin/ml. Successful uptake the
pLuxCDEfrp-TET plasmid was confirmed by restriction digest and the success of
the ligation reaction was confirmed by sequencing.
Transfection of pLuxAB and pLuxCDEfrp in HEK293 cells
Transfection was carried out in six-well Falcon tissue culture plates (ThermoFisher). The day prior to transfection, HEK293 cells were passaged into each
well at a concentration of approximately 1 × 105 cells/well and grown to 90 – 95%
confluence in complete medium. pLuxAB and pLuxCDEfrp-TET plasmid vectors
were purified from 100 ml overnight cultures of E. coli using the Wizard
Purefection plasmid purification system (Promega). On the day of transfection,
cell medium was removed and replaced and vector DNA mixed in a 1:1 ratio was
introduced using Lipofectamine 2000 (Invitrogen).
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Screening of stably transfected reporter cell lines
Twenty-four h post-transfection, the medium was removed and replaced with
complete medium supplemented with the appropriate antibiotic. Selection of
successfully transfected clones was performed by refreshing selective medium
every 4 – 5 d until all untransfected cells had died. At this time, colonies of
transfected cells were removed by scraping, transferred to individual 25 cm2 cell
culture flasks, and grown in complete medium supplemented with the appropriate
antibiotics.
To screen the resulting cell lines for the ability to regulate luxC transcription
in response to doxycycline, relative reverse transcription PCR (rt-PCR) was used
to determine the level of luxC mRNA present 24 h following the addition of 0, 10,
or 100 ng doxycycline/ml to the complete growth medium. To this end, each
isolated cell line was split into 4 25 cm2 cell culture flasks upon reaching 80%
confluence. Cells were then grown at 37°C and 5% CO2 until again reaching
~80% confluence. At this point, one of the flasks was routinely passaged to
maintain a stock of cells for future use. The remaining 3 flasks were spiked with
0, 10, or 100 ng doxycycline/ml and returned to the incubator. Twenty-four h
post doxycycline addition, cells were harvested and total RNA was isolated using
an RNeasy isolation kit (Qiagen). Isolated RNA was used directly for rt-PCR
analysis, and cell lines displaying the greatest range in luxC transcription
between 0 ng Doxycycline/ml treatment and either 10 ng or 100 ng
doxycycline/ml treatment were selected for bioluminescent screening.
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Bioluminescent measurement in response to doxycycline
Cell lines displaying the greatest upregulation of luxC gene transcription
following treatment with 10 ng and 100 ng Doxycycline/ml were passaged into 75
cm2 tissue culture flasks (Corning) and grown at 37°C and 5% CO2 until they
reached 90% confluence. Cells were then harvested by trypsinization and cell
number was determined as the average of two counts using a hemocytometer.
Approximately 1 × 106 cells per well were plated in triplicate in opaque 24-well
tissue culture plates (Costar) in DMEM without phenol red and supplemented
with 10% fetal bovine serum, 0.01 mM non-essential amino acids, and 0.01 mM
sodium pyruvate. Immediately post plating, wells were spiked with either 0, 10,
100, or 500 ng Doxycycline/ml. Photon counts were then recorded using an IVIS
Lumina in vivo imaging system and analyzed with Living Image 3.0 software
(Caliper Life Sciences). The change in light output over time was determined in
photons (p)/sec (s) for each well by averaging the photon output over integration
times of 10 min and reported with the standard error of the mean.
Bioluminescent measurement in response to toxic chemical exposure
To determine the ability of constitutively bioluminescent HEK293 cells to
function as a bioreporter for toxic chemical exposure, cells stably expressing
pLuxCDEfrp/pLuxAB were exposed to increasing concentrations of the cytotoxic
aldehyde n-decanal. HEK293 cells previously determined to be capable of
continuous bioluminescent output from the expression of the pLuxCDEfrp/pLuxAB
plasmids were passaged into 75 cm2 tissue culture flasks (Corning) and grown at
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37°C and 5% CO2 until they reached 90% confluence. Cells were then
harvested by trypsinization and cell number was determined as the average of
two counts using a hemocytometer. Approximately 1 × 106 cells per well were
plated in all wells in opaque 24-well tissue culture plates (Costar) in DMEM
without phenol red and supplemented with 10% fetal bovine serum, 0.01 mM
non-essential amino acids, and 0.01 mM sodium pyruvate. Triplicate wells were
treated with serial dilutions of n-decanal ranging from 0.1% to 1 × 10-5%, with a
control set receiving no n-decanal amendment to determine maximal
bioluminescent expression. Photon counts were then recorded using an IVIS
Lumina in vivo imaging system and analyzed with Living Image 3.0 software
(Caliper Life Sciences). The change in light output over time was determined in
photons (p)/sec/cm2/steridian (sr) for each well using integration times of 10 min
once every hour for 24 h and reported as the average of three runs with the
standard error of the mean.

Results
Regulation of luxC transcription in response to doxycycline dose
Following antibiotic selection of HEK293 cells co-transfected with
pLuxAB/pLuxCDEfrp-TET, 11 cell lines were established that were capable of
growing efficiently under selective media conditions. Each of these lines was
interrogated for the ability to up regulate luxC gene transcription following
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doxycycline amendment. The average CT value for luxC detection in negative
control cells containing no doxycycline was 13.6 (± 0.7) cycles. Following
amendment with 10 ng doxycycline/ml, the average CT value dropped to 11.9 (±
0.7), and following amendment with 100ng doxycycline/ml the average dropped
to 11.5 (± 0.6). Of the eleven cell lines tested, only three showed significant (p <
0.05) reductions in CT value at both 10 and 100 ng treatment levels as compared
to the negative control, and also between the 10 and 100 ng treatment levels
themselves (Table 8). The best performing cell line displayed a reduction of 3.5
cycles to reach CT upon amendment with 10 ng doxycycline/ml, which
corresponds to approximately 11-fold increase in luxC transcription. Upon
induction with 100 ng doxycycline/ml, this cell line displayed a reduction of 4.3
cycles to reach CT, an ~20-fold increase in transcription, although this was a
difference of less than one cycle to reach CT as compared to induction with 10 ng
doxycycline/ml, it was determined to be a statistically significant increase in
transcriptional level (p = 0.027). This cell line was chosen for determination of
bioluminescent output in response to doxycycline addition.
Bioluminescent production in response to doxycycline dose
Using the cell line previously determined to have the most dynamic
response to doxycycline treatment, cells were monitored to determine the
magnitude and dynamics of bioluminescent production over a 24 h period
following exposure to either 10 or 100 ng doxycycline/ml. Average background
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Table 8. Regulation of luxC gene transcription in response to doxycycline treatment.
Cell lines demonstrating a significant (p < 0.05) reduction in CT value between both negative control and 10 ng/ml doxycycline treatment
and negative control and 100 ng/ml doxycycline treatment are indicated with the * symbol. The cell line selected for further testing is
designated by the ** symbol.
10 ng Doxycycline/ml
Negative Control (0
Time
100 ng Doxycycline/ml Treatment
ng Doxycycline/ml)
Treatment
p Value vs.
p Value vs.
p Value vs. 10
∆ CT From
Cell
∆ CT From
∆ CT From 10
CT Value
Negative
Negative
Negative
ng/ml Treatment ng/ml Treatment
Negative
Line
Control
Control
# 1**
13.8 (± 0.2)
-3.5 (± 0.1)
< 0.01
-4.3 (± 0.2)
< 0.01
-0.8 (± 0.2)
0.03
#2
19.5 (± 0.1)
-1.5 (± 0.4)
0.05
-3.2 (± 0.1)
< 0.01
-1.7 (± 0.1)
0.04
#3

14.0 (± 0.8)

-1.4 (± 0.2)

0.2

-1.9 (± 0.1)

0.13

-0.4 (± 0.1)

0.17

# 4*

11.7 (± 0.1)

-1.2 (± 0.2)

0.02

-2.5 (± 0.2)

< 0.01

-1.2 (± 0.2)

0.02

#5

12.1 (± 0.1)

-1.2 (± 0.3)

0.05

-1.7 (± < 0.1)

< 0.01

-0.5 (± < 0.1)

0.3

#6

14.5 (± 0.2)

-3.3 (± 0.8)

0.04

-3.2 (± 0.3)

< 0.01

+0.1 (± 0.3)

0.95

#7

13.0 (± 0.1)

-2.1 (± 0.2)

< 0.01

-2.6 (± 0.1)

< 0.01

-0.4 (± 0.1)

0.12

# 8*

12.5 (± 0.2)

-1.2 (± 0.1)

0.02

-2.0 (± 0.2)

< 0.01

-0.9 (± 0.2)

0.04

#9

11.8 (± 0.2)

-0.7 (± 0.1)

0.1

+0.3 (± 0.3)

0.47

+0.1 (± 0.3)

0.08

# 10

12.6 (± 1.5)

-2.6 (± 1.2)

0.25

-1.1 (± 0.2)

0.56

+1.6 (± 0.2)

0.31

# 11

14.2 (± 0.2)

-0.2 (± 0.4)

0.73

-.9 (± 0.3)

0.08

-0.7 (± 0.3)

0.23
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bioluminescence detection from cells that did not receive doxycycline treatment
was determined to be 11,000 (± 205) p/s. Average total flux from cells treated
with 10 ng doxycycline/ml was not increased significantly (p = 0.06), although it
did trend upwards to 11,500 (± 200) p/s. Treatment with 100 ng doxycycline/ml,
however, further increased the total flux to 12,500 (± 200) p/s, a significant
increase over both the negative (p = 1.1 × 10-5) and over the 10 ng/ml treatment
(p = 9.2 × 10-4). These values remained relatively constant over the full course of
the assay (Figure 16), with ranges of only 2,010, 1,900, and 1,800 p/s for the
negative control, 10 ng, and 100 ng doxycycline/ml treatments respectively
following the initial evaluation at 1 h post treatment. It was possible to
significantly distinguish the 100ng/ml treatment level from background at all but
the 5 h post treatment time point. While it was possible to significantly
distinguish the 10ng/ml treatment level at some of the time points, it was never
consistently greater than that of the untreated control cells (Table 9). After it was
discovered that bioluminescent production could be induced with treatment at
100 ng doxycycline/ml, but not at 10 ng doxycycline/ml, cells were treated with
500 ng doxycycline/ml to determine if higher treatment levels would be capable
of inducing further increases in bioluminescent production. However, it was
discovered that this treatment was not able to induce any further increase in
bioluminescent output.
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Figure 16. Bioluminescent production following treatment with varying levels of
doxycycline.
Cells treated with 100 ng doxycycline/ml produced significantly greater bioluminescent flux (p <
0.05) than untreated cells at all time points except for 5 h post treatment, while cells receiving 10
ng doxycycline/ml produced greater bioluminescent flux only intermittently.
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Table 9. Detection of significantly significant changes in bioluminescent production following doxycycline treatment.
HEK293 cells containing promoter sequences capable of regulating luxC and luxE gene expression in response to doxycycline levels can
be used to report on exposure to increased levels of doxycycline in the media. Green boxes indicate time points where significant (p <
0.05) up regulation of bioluminescent production was detected. Hatched red boxes indicate that no significant (p > 0.05) increase in
bioluminescent production was detected.
Time Post Doxycycline Treatment
1h

2h

3h

4h

5h

6h

7h

8h

9h

100 ng
Treatment
10 ng
Treatment

131

10 h

11 h

12 h

13 h

14 h

15 h

16 h

17 h

Use of constitutively bioluminescent cells as biosensors for n-decanal
exposure
Constitutively bioluminescent HEK293 cells expressing pLuxAB/pLuxCDEfrp
were exposed to increasing levels of the cytotoxic aldehyde n-decanal and the
rate and magnitude of bioluminescent production was monitored to determine the
bioavailability of this toxicant to a mammalian cell line. It was observed that
treatment with 0.1% n-decanal reduced bioluminescent output immediately
following addition, with all of the surveyed time points displaying significantly
down regulated production of light (Table 10). Treatment with 0.01% n-decanal
also had deleterious effects on bioluminescent production, however, due to the
reduced concentration, these effects were not consistently observable until 4 h
after addition (Table 10). The remaining treatment levels, while not capable of
inducing increases in bioluminescence, could not be statistically differentiated
from cells not receiving treatment (Figure 17).

Discussion
These findings represent the first use of autonomous bioluminescent
production from a mammalian cell line being harnessed to directly detect the
bioavailability of compounds of interest. The unique ability of the lux genes to
produce a bioluminescent signal that is practically background free, without
exogenous stimulation, opens the door for future development of high
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Figure 17. Bioluminescent profile of constitutively bioluminescent HEK293 cells following
decanal treatment.
Treatment with 0.1% decanal leads to immediate reductions in bioluminescent output, while
treatment with lower concentrations produces more subtle reductions in output. Only treatment
with 0.1% and 0.01% decanal adversely effected bioluminescent production, while no treatment
levels surveyed were capable of increasing bioluminescent production.
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Table 10. Detection of significantly different changes in bioluminescent production following doxycycline treatment.
Hashed red boxes indicate bioluminescent profiles similar to control (p > 0.05). Green boxes represent bioluminescent profiles lower than
untreated control cells (p < 0.05). At concentrations below 0.01% decanal it was not possible to differentiate the luminescent profile from
that of the untreated control cell line. Intermittent deviation in bioluminescent flux was detected beginning at 40 min post decanal addition
and became constant after 4 h at a concentration of 0.01%, while treatment with 0.1% decanal was able to be differentiated from control at
all time points surveyed.
Time Post Decanal Addition
0 min

10 min

20 min

30 min

40 min

Decanal

0.00001%
0.00010%
0.00100%
0.01000%
0.10000%
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50 min

1h

1.5 h

2h

2.5 h

3h

3.5 h

4+ h

throughput, on-line monitoring systems. These types of screening systems have
not previously been possible in the mammalian cellular background because of
the photobleaching effects related to constant stimulation of fluorescent reporters
or the prohibitively high cost of constant substrate profusion required for
alternative bioluminescent reporters. With these barriers circumvented by the
ability of the lux-expressing cells to produce light autonomously, there is now the
potential to provide a facile method for screening large numbers of compounds
simultaneously and directly relating the findings to human bioavailability.
The ability of lux expression to function as a traditional bioreporter by
modulating the expression of the luxC and luxE genes under control of a
tetracycline responsive promoter has been demonstrated in these experiments.
The luxC and luxE genes were chosen as the regulatable genes because
previously published literature has suggested that regulation of the luxC and luxE
genes would provide the most digital control over bioluminescent expression
using mathematical models (Welham and Stekel 2009). While this work has not
demonstrated that this is in fact the most efficient method of regulation, it has
validated that expression of the luxC and luxE genes can be used successfully to
modulate bioluminescent expression at statistically significant levels (p < 0.05).
The luxC and luxE genes play a crucial role in the production and
regeneration of the myristyl aldehyde substrate required by the lux luciferase
enzyme in order to produce bioluminescence. The luxE gene encodes an acylprotein syntetase that activates an intermediate fatty acid compound to provide
the energy required for its future reduction to an aldhyde. It is the luxC gene,
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which encodes a fatty acid reductase, that performs this reduction of the fatty
acid precursor to form the alehyde that ultimately takes part in the bioluminescent
reaction. Previous work has demonstrated that constitutive expression of the
luxA and luxB genes that form the actual luciferase enzyme is not cytotoxic
(Patterson, Dionisi et al. 2005) and that expression of these genes alone is not
sufficient to elicit bioluminescent production without the function of the remainder
of the lux cassette genes (Close, Patterson et al. 2010). It has also been shown
that high levels of aldehyde expression can be toxic in organisms exogenously
expressing the lux genes (Hollis, Lagido et al. 2001). Taken together, these data
suggest that regulation of aldehyde production within the mammalian cell will be
the most efficient means for controlling bioluminescent expression while
simultaneously maintaining efficient conditions for cellular growth and
metabolism.
While it may have been more efficient to control only a single gene (i.e.
only luxC or luxE) rather than multiple genes to serve this purpose, it was
necessary to simultaneously regulate two genes in order to properly mimic the
polycistronic nature of the cassette within the mammalian host cells. Regulation
of only one gene would have required re-engineering of the previously validated
lux vectors, as well as the possible introduction of a third plasmid. This prospect
would have been detrimental to transfection efficiency and significantly
decreased the chances of successfully establishing a stable cell line expressing
all three plasmid constructs.
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Treatment of cells expressing the luxC and luxE genes under the control
of the tetracycline responsive promoter with 100 ng doxycycline/ml was able to
elicit a significant up regulation in bioluminescent output (p = 1.1 × 10-5) following
a relatively short incubation period of 1 h (Figure 17). This time period is in line
with previously published reports that have indicated the tetracycline responsive
promoter is strong enough to produce detectable levels of its downstream gene
product in as little as 30 min (Yarranton 1992; Gossen and Bujard 1993). It is not
known why the bioluminescent levels of the control and 10 ng doxycycline/ml
treated cells increased transiently during the 5 h time point (Figure 16). This
anomalous increase in flux from the control cell line represents the only surveyed
time point where it was not possible to statistically differentiate the signal from
cells treated with 100 ng doxycycline/ml from the negative control, however, it
maintained the trend of non-statistically differential expression between the
control and 10 ng doxycycline/ml treated cell lines. The most parsimonious
explanation is that there was a mechanical anomaly with the imaging equipment
leading to false positive levels of photon acquisition counts over an area of the 24
well plate that contained both the negative control and 10 ng doxycycline/ml
treated cells, as these were spatially adjacent during imaging. The 100 ng
doxycycline/ml treated cells remained distal from this section of the plate, and
therefore may not have been affected by the anomaly, explaining why there was
not a corresponding increase in measured bioluminescent flux for all three
treatment levels at the 5 h time point.
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Levels of bioluminescent flux from cells treated with 100 ng
doxycycline/ml were smaller than those detected from similar numbers of
constitutively bioluminescent cells in culture. When the luxC and luxE genes
were continuously expressed under the control of the EF1-α promoter the
maximum level of radiance was measured at 4.5 (± 0.16) × 105 p/s, whereas,
with the luxC and luxE genes placed under the control of the tetracycline
responsive promoter and induced with 100 ng doxycycline/ml, the maximum
measured flux was 1.3 (± 0.03) × 104 p/s. This is most likely due to a
combination of the improved efficiency of the EF1-α promoter as compared to the
tetracycline responsive promoter and the increases in transcriptional efficiency
imparted during continuous expression.
Due to the discrepancy in luminescent flux between tetracycline
responsive cell lines and those displaying constitutive expression, increases in
treatment levels above 100 ng doxycycline/ml were attempted, however, none
were shown to further increase bioluminescent output. These results indicate
that the tetracycline responsive lux reporter cells have a relatively narrow
detection range, and therefore would not make efficient laboratory reporter
strains at this time. There are, however, further avenues that could be explored
to improve their performance. The first steps in this direction would be the
redesign of the plasmid vectors to regulate expression of only a single lux gene,
or the choice of alternative lux genes as points of regulation for reporter function.
General considerations for optimization of the lux system that could be applied as
well will be discussed extensively in chapter V.
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Due in part to the poor performance of lux expressing cells to act as a
bioreporter for specific compound detection, it was further investigated whether
or not constitutively bioluminescent mammalian cells could function as
biosensors for toxicological screening. These unique cells are ideal platforms for
real-time monitoring of the mammalian bioavailability of potentially toxic
compounds, an assay that has not been previously available. To determine their
effectiveness in this roll, cells were exposed to n-decanal, a cytotoxic aldehyde
similar to the product of the bacterial bioluminescent reaction, and the minimum
exposure level capable of reducing bioluminescent production was determined.
Decanal was chosen for the initial assay because it can serve a three-fold
purpose. As a similar product to that of the reaction catalyzed by the actions of
the luxCDE genes (Meighen 1979), there have long been concerns over the
potential cytotoxicity of these types of compound when the lux system is
expressed in non-native organisms (Hollis, Lagido et al. 2001). By using
changes in bioluminescence to monitor for the effects of n-decanal on the
HEK293 cell line it was possible to determine 1) if small supplements of the
compound can increase bioluminescent intensity, 2) at what level the compound
becomes toxic to the cell, and ultimately, 3) if a constitutively bioluminescent
mammalian cell line can function as a reporter system for toxic chemical
exposure.
It was hypothesized that slight increases in n-decanal availability would
lead to increased bioluminescent output. Previous work had indicated that when
additional levels of n-decanal were made available to cell extracts containing the
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lux proteins, it was possible to increase overall bioluminescent output in vitro
(Close, Patterson et al. 2010). This effect was not observed during in vivo testing
(Figure 17) however, and none of the time points surveyed produced a result
whereby a cell population treated with any level of decanal produced significantly
greater bioluminescent flux than the untreated control line. The small, aliphatic
nature of n-decanal allows it to cross the membrane of Gram negative bacteria
(Sizemore, Geissdorfer et al. 1993), and our data supports the hypothesis that
the saturated ten carbon tail also allows the molecule to pass through the lipid
bilayer of mammalian cells. Using the newly developed assay it was confirmed
that n-decanal treatment is adversely toxic (high levels of the compound will fix
cells in a manner similar to formaldehyde) and will become detrimental to cellular
health at concentrations required to generate the diffusive force required to cross
the membrane. It is possible, however, that there are alternative explanations for
the failure of low level n-decanal treatment to increase bioluminescent flux. The
cell could be reaching an equilibrium where the additional influx of aldehyde is
boosting bioluminescent production levels, but simultaneously negatively
effecting cellular metabolism, thereby reducing overall bioluminescent yield. This
situation seems unlikely, given the observation that there is no effect over three
orders of magnitude of aldehyde concentration. It is more parsimonious that the
low levels of aldehyde concentration do not provide enough diffusive force to
allow n-decanal to cross into the interior of the cell through the lipid bilayer.
Despite the inability of low levels of aldehyde treatment to stimulate
bioluminescent production, it was clear that at and above concentrations of
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0.01% the aldehyde became toxic to the HEK293 cell line (Table 10). While
treatment with 0.1% decanal reduced bioluminescent output at all time points
surveyed, treatment with 0.01% was not able to consistently reduce
bioluminescence until 4 h after addition. These results are comparable with
previously published reports that demonstrated the ability of aldehyde to diffuse
into Gram negative bacteria at concentrations in the range of ~ 0.25 – 50 × 10-5
M (Rogers and McElroy 1958). Our 0.01% decanal treatment corresponds to a
concentration of ~64 × 10-5 M. While the previous experiments used the slightly
longer dodecanal in place of decanal (C12 compared to C10), less of that
aldehyde is required to enter the cell in order to elicit a similar bioluminescent
response because the longer chain aldehydes have been shown to produce a
greater bioluminescent signal upon utilization in the lux reaction despite their
slower penetration of the cell wall (Rogers and McElroy 1958). These data
suggest that the concentration range of 10-5 M is the point where decanal is able
to cross the cell wall at a rate greater then it is able to be cleared by aldehyde
metabolizing enzymes.
The initial production of bioluminescence within error of the positive
control indicates that for the first 0.5 h, a sufficient concentration of aldehyde has
not entered into the cells to elicit a change in metabolism or cellular health. The
fluctuations in bioluminescent production over the next 2 h indicate that aldehyde
has entered into the cell, but is likely being processed by endogenous aldehyde
metabolizing proteins, whereas the distinct reduction in bioluminescence
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following the 4 h time point suggests that the concentration of aldehyde has
become too great to be cleared and has begun causing cellular damage.
The clear distinction between concentrations of aldehyde that affect
bioluminescent production, and those that do not have an affect, suggest that
constitutively bioluminescent mammalian cells can be used as sensors for
monitoring the bioavailability of toxic compounds in real time. Specifically the
treatment of cells with 0.01% decanal shows that the real-time nature of the lux
expression system can allow researchers to determine not only the presence or
absence of an affect from their treatment of interest, but can also do so in a timedependent manner. The autonomous nature of this reaction demonstrated by
these results will allow for the development of biosentinel devices capable of
acting remotely to detect and report directly on the mammalian bioavailability of a
variety of biomedically relevant compounds in a way that is not feasible using
substrate dependent luciferase systems.
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CHAPTER V
Initial Optimization Of The Mammalian-Adapted Bacterial
Bioluminescence System And Determination Of Objectives For
Future Improvements

Introduction
The use of mammalian-adapted bacterial luciferase (lux) genes as a
reporter system in human cells is still in its infancy. While the initial results
detailed in this work are encouraging, the future of the mammalian lux system is
still being written. As the newest of the mammalian-compatible reporter options,
the lux system has not had the advantage of optimization that comes from
widespread adoption and evaluation by multiple research groups.
Thus far, all of the popular genetic-based (i.e. those derived directly from
living organisms) fluorescent and bioluminescent reporter systems currently
being employed for small animal imaging have had the advantage of multiple
refinements in order to increase their efficiency under standard laboratory
conditions. Perhaps the best example of these incremental improvements has
been with the widely used green fluorescent protein (GFP). Originally detailed in
1962 (Shimomura, Johnson et al. 1962), the GFP protein has undergone
extensive modification from its native state in the last ~50 years in order to
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compensate for the traits that make it less attractive for use as an imaging target.
The genetic structure of the GFP protein has been altered repeatedly in order to
allow it to fold properly in mammalian cells at the relatively increased
temperature of 37°C (Crameri, Whitehorn et al. 1996), to prevent dimerization
under the high levels of constitutive expression that are preferred for facile image
acquisition (Zacharias, Violin et al. 2002), and mutated myriad times in order to
alter the signal emission wavelength so that it can be used in tandem with other
reporters, or detected with greater efficiency through living tissue (Heim, Prasher
et al. 1994; Heim and Tsien 1996; Ormo, Cubitt et al. 1996). Each of these
incremental changes have led to the development of a protein that, while the
same in name, in some implementations, can not even be spectrally identified as
its native precursor.
The same can be said for alternative bioluminescent proteins such as
firefly luciferase (Luc). Recently there have been modifications engineered into
the luc gene, leading to is commercial replacement with luc2, a modified version
that has been designed to improve translational efficiency in the mammalian
cellular background and has also been destabilized to promote lower background
and increased induction levels (Promega 2009). As the use of optical imaging
technologies continues to spread in the scientific community, there will continue
to be an increasing drive for the development of new, enhanced versions of the
Luc protein, just as there has for GFP, in order to fill the diverse requirements of
new researcher’s specific experimental designs.
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If use of the lux reporter system spreads to even moderate levels among
those actively engaged in optical imaging, there will no doubt be great interest in
enhancing its bioluminescent characteristics, just as there has been with other
widely adopted reporter systems. To this end, the groundwork for future
development and optimization of the lux system has been laid out, with
increasing the bioluminescent flux of the system as the primary goal. Under its
current implementation, the mammalian-adapted lux system cannot produce
levels of bioluminescent flux as high as any of the commercially available
bioluminescent proteins can, following amendment with their luciferin substrates.
Enhancing the bioluminescent flux of the lux system to achieve levels of flux on
par with the alternative systems would overcome this deficiency, which is viewed
as the main hurdle to its widespread use in the optical imaging community, and
prevent it from being used solely as a niche-based reporter for experimental
designs that require bioluminescent production without substrate amendment.
To determine points for future optimization of the lux system that could
increase bioluminescent production, the function of the lux genes within the
HEK293 mammalian cell line was first investigated. While the function of the
luxA and luxB genes has previously been evaluated extensively (Patterson,
Dionisi et al. 2005; Close, Patterson et al. 2010), the focus of these experiments
was to evaluate the function of the remaining luxC, luxD, luxE, and frp genes that
are responsible for establishment and regeneration of the aldehyde and FMNH2
substrates required for bioluminescent production. The luxC, luxD, and luxE
genes produce protein products that work together in a complex to supply the
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myristyl aldehyde substrate (Meighen 1991). Their codependence allows them
to be evaluated simultaneously, because a deficiency in any one will adversely
effect the production of bioluminescence in vivo. The frp gene acts
independently, and therefore was evaluated separately in order to determine its
function in the regeneration of cytosolically available FMNH2.
Because the function of these genes is in part dependent on the efficiency
of their expression in the mammalian cellular environment, the translational
efficiency imparted by the internal ribosomal entry site (IRES) elements that were
included to spur translation of the lux genes while mimicking the polycistronic
nature of the original bacterial operon was also investiagated. The use of a 2A
linker site as an alternative to the IRES element was investigated and the
resulting changes in in vitro bioluminescent production levels were compared.
The 2A element was chosen because it performs the same basic function of the
IRES element by generating multiple protein products from a single mRNA under
the control of a single promoter element. However, the means by which the
protein products are created are very different.
IRES elements are relatively large sequences of DNA that, upon
transcription into mRNA, form a secondary structure capable of attracting and
binding a ribosome to initiate translation of the downstream gene (Lupez-Lastra,
Rivas et al. 2005). On the other hand, 2A elements are short, in-frame, linker
regions that separate two in-frame ORF’s driven off of a single promoter. During
translation of the 2A sequence region the nascent amino acid sequence interacts
with the exit tunnel of the ribosome, causing a “skipping” of the last peptide bond
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at the C terminus of the 2A sequence. Despite this missing bond, the ribosome
is able to continue translation, creating a second, independent protein product.
The short nature of the sequence (they average 10 amino acids in length) and
highly efficient 1:1 stoichiometry of these sequences give them many advantages
over the more bulky IRES elements (de Felipe 2004).
By determining if increased efficiency of the aldehyde and/or FMNH2
regulating genes increased bioluminescent output in the mammalian-adapted lux
system, it allows future research to focus on improving the specific aspects of the
lux system that can lead to the most beneficial improvements in the shortest
amount of time. Likewise, the comparison of IRES-based polycistronic
expression with a 2A-based expression system highlights if the exchange of
these linker regions provides tangible advantages beyond the simple reduction in
overall system size and repetition of large sequences of DNA in the plasmid
vectors. It was not expected that these initial investigations would lead directly to
the development of improved lux function in the mammalian cellular background,
but instead, that they would provide the framework for moving forward with the
first steps of what will hopefully one day be a rich history of lux development.
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Materials And Methods
Replacement of IRES elements with 2A elements
Synthesis of 2A elements

To determine if the IRES element linking together the luxA and luxB genes
in the original pLuxAB construct was detrimental to transcriptional/translational
efficiency, it was replaced with a synthetic 2A element. This sequence was
previously characterized by Ibrahimi et. al (Ibrahimi, Velde et al. 2009), and was
flanked by two identical sequences composed of three glycines, a serine, and
three more glycines. The final construct was synthetically assembled as
GGGSGGGEGRGSLLTCGDVEENPGPGGGSGGG and placed upstream of the
luxB gene commercially (GeneArt). The purchased construct was cloned into
pLuxAB using the upstream EcoNI and downstream SalI restriction sites to
replace the IRES element, creating the pTa2AluxAB plasmid, which contained a
CMV promoter, the luxA gene, the Ta2A linker region, and the luxB gene.
Transfection of HEK293 cells

Transfection was carried out in six-well Falcon tissue culture plates
(Thermo-Fisher). The day prior to transfection, HEK293 cells were passaged
into each well at a concentration of approximately 1 × 105 cells/well and grown to
90 – 95% confluence in complete medium. The previously described
pLuxCDEfrp:CO/pLuxAB or pLuxCDEfrp:WT/pLuxAB vectors (Close, Patterson et al.
2010) as well as the pTa2AluxAB plasmid were purified from a 100 ml overnight
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culture of E. coli using the Wizard Purefection plasmid purification system
(Promega). On the day of transfection, cell medium was removed and replaced
and vector DNA was introduced using Lipofectamine 2000 (Invitrogen). Twentyfour h post-transfection, the medium was removed and replaced with complete
medium supplemented with the appropriate antibiotic. Selection of successfully
transfected clones was performed by refreshing selective medium every 4 – 5 d
until all untransfected cells had died. At this time, colonies of transfected cells
were removed by scraping, transferred to individual 25 cm2 cell culture flasks,
and grown in complete medium supplemented with the appropriate antibiotics.
in vitro bioluminescent measurement
Total protein was extracted from co-transfected pLuxCDEfrp:CO/pLuxAB or
pLuxCDEfrp:WT/pLuxAB cell lines (Close, Patterson et al. 2010) or the pTa2AluxAB
transfected cell line using a freeze/thaw procedure. Cells were first grown to
confluence in 75 cm2 tissue culture flasks (Corning), then mechanically detached
and resuspended in 10 ml of PBS. Following collection, cells were washed twice
in 10 ml volumes of PBS, pelleted and resuspended in 1 ml PBS. These 1 ml
aliquots of cells were subjected to three rounds of freezing in liquid nitrogen for
30 sec, followed by thawing in a 37°C water bath for 3 min. The resulting cell
debris was pelleted by centrifugation at 14,000g for 10 min and the supernatant
containing the soluble protein fraction was retained for analysis.
Bioluminescence was measured using an FB14 luminometer (Zylux) with
a 1 sec integration time. To prepare the sample for in vitro bioluminescent
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measurement, 400 µl of the isolated protein extract was combined with 500 µl of
either oxidoreductase supplemented light assay solution containing 0.1 mM
NAD(P)H, 4 µM FMN, 0.2% (w/v) BSA and 1 U of oxidoreductase protein isolated
from V. fischeri (Roche), or oxidoreductase deficient light assay solution (distilled
water substituted for the 1 U of oxidoreductase protein). Following the initial
bioluminescent reading, samples were amended with 0.002% (w/v) n-decanal
and the readings were continued to determine if additional aldehyde could
increase light output. All bioluminescent signals were normalized to total protein
concentration as determined by BCA protein assay (Pierce) and reported as
relative light units (RLU)/mg total protein. All sample runs included processing of
cell extracts from HEK293 cells stably transfected with pLuxAB as a control for
light expression upon amendment.

Results
in vitro supplementation assays to determine efficiency of gene function in
vivo
Supplementation with NAD(P)H:flavin oxidoreductase protein

Previous work with the lux system in lower eukaryotes has shown the initial
substrate, FMNH2, to be a limiting reagent in the reaction (Gupta, Patterson et al.
2003). To determine if this was the case in HEK293 cells, in vitro
supplementation assays were performed with the addition of 1 U of
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NAD(P)H:Flavin oxidoreductase protein isolated from Photobacterium fischeri.
Protein extracts from cells containing the lux genes in either their codonoptimized or wild-type forms were subjected to in vitro analysis to determine if the
addition of oxidoreductase protein could improve light output. Upon addition of
the flavin oxidoreductase protein, the average bioluminescent output increased
from 1,400 (± 200) RLU/mg total protein to 111,500 (± 10,500) RLU/mg total
protein in pLuxCDEfrp:WT containing cells (Figure 18A) and from 1,600 (± 200)
RLU/mg total protein to 245,000 (± 20,500) RLU/mg total protein in pLuxCDEfrp:CO
containing cells (Figure 18B).
Supplementation with aldehyde

The synthesized co-substrate required for light production in the lux
system is a long chain aliphatic aldehyde that binds to the luciferase and is
oxidized (Meighen 1991). The ability, conferred by the luxCDE genes, to produce
and recycle the aldehyde substrate endogenously makes lux a uniquely
beneficial reporter system. To assay for the production of aldehyde, cell extracts
were supplemented with 0.002% (w/v) n-decanal, as this has previously been
shown capable of functioning in place of the natural aldehyde substrate (Dunn,
Michalis et al. 1973; Meighen, Bogacki et al. 1976; Gupta, Patterson et al. 2003;
Szittner, Jansen et al. 2003; Patterson, Dionisi et al. 2005). When supplied with
aldehyde, both the pLuxCDEfrp:WT and pLuxCDEfrp:CO containing cell extracts
showed increases in bioluminescent output. Cell extracts from wild-type
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Figure 18. Supplementation assays demonstrating the functionality of the luxCDEfrp
genes in the mammalian cell environment.
Supplementation with 1 U oxidoreductase protein significantly increased light output in cell
extracts from (A) wild-type and (B) codon-optimized cell lines. Supplementation with 0.002% ndecanal resulted in increased bioluminescent output in both the (C) wild-type and (D) codonoptimized cell extracts as well, but at a lower magnitude than oxidoreductase supplementation.
Values are the average of four trials, and are reported with the standard error of the mean.
Originally published in (Close, Patterson et al. 2010).
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containing cells showed an increase from 1,400 (± 200) RLU/mg total protein to
22,000 (± 1,500) RLU/mg total protein (Figure 18C). Extracts from
codon-optimized cells increased from the baseline of 1,600 (± 200) RLU/mg total
protein to 94,000 (± 10,800) RLU/mg total protein (Figure 18D).
Determination of bioluminescent output from HEK293 cells containing 2A
linked luxAB genes
Five cell lines were recovered that stably expressed the 2A linked luxAB
gene sequences following transfection with pTa2AluxAB. These five lines were
subjected to in vitro analysis to determine if they were capable of producing more
light than approximately equal numbers of cells stably expressing the IRES
linked luxAB gene sequences from pLuxAB. It was determined that the average
bioluminescent signal from cells containing 2A linked lux genes was ~5500 (±
3700)% greater than that from cells with IRES linked lux genes. The major
contributing factor to the large standard error of the mean was a single cell line
that achieved 20,500% greater bioluminescent production than the pLuxAB
control (Table 11). When excluded from the calculations, this reduced the
average bioluminescent production to ~1,800 (± 230)% over IRES linked gene
expression.
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Table 11. Bioluminescent expression from in vitro expression of luxA and luxB genes
linked by 2A elements is consistently higher than that of IRES linked luxA and luxB genes.

IRES linked luxA / luxB
2A linked luxA / luxB #1
2A linked luxA / luxB #2
2A linked luxA / luxB #3
2A linked luxA / luxB #4
2A linked luxA / luxB #5
HEK Neg

Bioluminescent Output
(RLU/mg Protein)

% of Control

1,719,940
21,103,893
35,885,713
29,711,493
352,781,297
38,499,816
3,736

N/A
1,227
2,087
1,728
20,511
2,238
0
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Discussion
Although the codon-optimized lux system is functioning at a level capable
of producing bioluminescent detection under a wide array of conditions, it is clear
that concentrations above the available levels of either the FMNH2 (Figure 18 A
and C) or aldehyde substrates (Figure 18 B and D) will result in increased
bioluminescent output. However, an increase in aldehyde production can be
cytotoxic, as has been demonstrated in luxAB containing S. cerevisiae and
Caenorhabditis elegans cells (Hollis, Lagido et al. 2001). This may lead to a
scenario where the luxCDE containing cells that most efficiently produce the
aldehyde substrate are selected against during the initial period of growth
following transfection with luxCDEfrp due to slowed growth and/or elevated
cytotoxicity. The increased presence of aldehyde may therefore cause those
cells capable of most efficiently producing aldehyde to inhibit their own growth,
mimicking the effects of antibiotic selection and causing them to be out-competed
in culture by cells expressing lower levels of aldehyde production. Mathematical
models of the lux system have indicated that the production of light is much more
sensitive to the aldehyde turnover rates modulated by the luxCE genes
responsible for encoding the reductase and synthase that convert the myristyl
acid to a myristyl aldehyde than it is to the concentration of luciferase dimer
formed by the luxAB genes responsible for catalyzing the reaction and facilitating
the production of light. The model predicts that a reduction in the concentration
of the luxC or luxE gene products will lead to a drastic reduction in light output
(Welham and Stekel 2009). If true, then it is hypothesized that the cytotoxicity of
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aldehyde within the cell may be a non-issue in regards to selecting cell lines that
can function in bioluminescent imaging assays. Cells with cytotoxic levels of
aldehyde production will be removed early in the selection process due to slow
growth rates and inability to compete with faster growing cell lines during the
antibiotic selection phase following transfection. Similarly, cells with low levels of
luxCDE expression will not generate high levels of bioluminescence during in
vitro screening of luxCDEfrp containing cell lines. This would tend to encourage
only the selection of cell lineages capable of producing just enough aldehyde to
drive the lux reaction, but not enough to impair cellular growth and function, as
platforms for biosensor development. Experiments aimed at determining if
expression of the lux cassette genes (and, by extension, the products of their
associated reactions) altered cellular metabolism and growth rates have
supported these predictions.
As shown in Figure 18, the availability of FMNH2 appears to contribute as
a limiting reagent for the lux reaction in a mammalian cell environment.
Supplementation with as little as 1 U of oxidoreductase protein in vitro led to
relatively large (up to 151-fold) increases in bioluminescent output levels, while
supplementation with 0.002% n-decanal produced less substantial (up to 58-fold)
increases in light production. When supplemented with additional
oxidoreductase protein to drive the turnover of FMN to FMNH2, the average
production of light increased by 82-fold in wild-type cell extracts (Figure 18A) and
by 151-fold in extracts from cells containing codon-optimized lux genes (Figure
18B). The increases in light production attributed to additional FMNH2 were
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consistently of greater magnitude than those associated with aldehyde
supplementation. The highest increase in light output achieved through addition
of n-decanal was 58-fold in cells containing codon-optimized genes (Figure 18D),
compared with only a 16-fold increase in light output from cell extracts cotransfected with the wild-type genes (Figure 18C). These results suggest that
codon optimization of the remaining luxCDE genes from P. luminescens allows
for more efficient processing of the available substrates in the mammalian cell
environment, but does not allow for production levels that rival the ideal
conditions of in vitro substrate supplementation where the bioluminescent output
would be limited only by the efficiency of the LuxAB luciferase dimer. When
supplemented with identical levels of aldehyde, cell extracts containing codonoptimized luxCDEfrp genes were able to produce over four times as much light
as those containing the wild-type genes (Figure 18 C and D). A similar result
was obtained under oxidoreductase supplementation, with extracts from the
codon-optimized cell lines producing over twice as much light as their wild-type
counterparts (Figure 18 A and B).
The data also indicate that the use of IRES elements is a contributing
factor for inefficient bioluminescent expression in the mammalian cellular
background. As demonstrated in Table 11, exchanging the IRES element for a
2A element lead to increased bioluminescent output in all cell lines that were
stably isolated. It is important to note that during the process of Lipofectaminebased mammalian cell transfection, it is not possible to effectively control the
location of gene insertion into the genome, nor is it possible to regulate the
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number of integration events that take place. Taken together, these factors can
help to explain the large discrepancy in bioluminescent output between clone
number 4 and the remaining pTa2AluxAB transfected cell lines. It is conceivable
that the resulting increase in bioluminescent production from cell line number 4 is
the result of multiple luxAB gene insertions into the parental cell genome.
Assuming all of these insertions remain under the control of the constitutively
active CMV promoter, this will afford the cell with multiple locations for
simultaneous production of LuxAB protein. Because all cell lines were tested in
vitro, each was supplied with an identical level of the remaining required
substrates for bioluminescent production. Under these circumstances, the cell
line expressing the most LuxAB protein would be capable of producing the most
light.
To compare and contrast the light output data, all readings are normalized
to the total soluble protein concentration from each cell line. This method does
not allow for determination of the total amount of Lux protein expression or even
the ratio of Lux protein to endogenous protein available during the assay. As a
result, there is no way to calculate if the increase in bioluminescent production is
the result of multiple insertion events during the course of transfection, or if it is
the result of increased up regulation of luxAB gene transcription due to their
location within the genome. An additional explanation is that the luxAB genes
transfected into clone number 4 were inserted into a euchromatic region of the
genome as opposed to a more heterochromatic portion, or that they inserted
near another strong promoter, which has caused them to be expressed at even
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higher levels then would be found under the control of the CMV promoter alone.
This explanation is less likely, however, because recent work has demonstrated
that the CMV promoter is one of the most active promoters known in the HEK293
cellular environment (Qin, Zhang et al. 2010).
Regardless of the genetic reasons underlying the heightened
bioluminescent production of clone number 4, it is important to note that the
remaining 2A containing clones averaged ~1,800 (± 230)% over their IRES linked
counterparts. This increase was relatively consistent (± 230%), indicating that
increases in this range should be routinely achievable when IRES elements are
exchanged for 2A elements. Although it is not yet known whether exchanging
the IRES elements governing the expression of the remaining lux genes will have
similar effects on autonomous bioluminescent expression, it is clear that the use
of 2A elements are an attractive alternative due to their smaller size and
increased efficiency at driving downstream gene expression.
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CHAPTER VI
Summary And Conclusions

This investigation has lead to the development and documentation of the
first published autonomously bioluminescent reporter system capable of
functioning in the mammalian cellular environment. This type of system can be
employed either in tandem or in replacement of traditional bioluminescent and
fluorescent mammalian imaging systems such as firefly luciferase (Luc) and
green fluorescent protein (GFP) to provide investigators with an additional tool for
the interrogation of biological function in cell culture or small animal based
imaging experiments. Although the mammalian-adapted bacterial luciferase (lux)
system has not yet been subjected to enhancement and optimization, it can be
deployed in its present state and used for the acquisition of data under protocols
similar to those currently in place for alternative bioluminescent reporter proteins.
The following conclusions have been drawn from this investigation in regards to
the initial hypotheses:

Hypothesis 1: Through a process of poly-bicistronic expression of
Photorhabdus luminescence genes codon-optimized for expression in
mammalian cells it will be possible to autonomously produce a
bioluminescent signal in the human HEK293 cell line.
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It has been shown that poly-bicistronic expression of codon-optimized P.
luminescence lux genes is capable of inducing constitutive bioluminescent
production in the human HEK293 cell line. The codon optimization process was
not shown to alter the pattern of bioluminescent expression over time as
compared to expression of the wild-type genes, however, it has been
demonstrated that the codon-optimization process leads to increased
bioluminescent production. This increase is presumably due to the enhanced
efficiencies in transcription and translation associated with the codon optimization
process (Kim, Oh et al. 1997; Slimko and Lester 2003; Mechold, Gilbert et al.
2005; Barrett, Sun et al. 2006). Despite the production and regeneration of
potentially cytotoxic substrates required for constitutive bioluminescent
production, the expression of codon-optimized lux genes has not been shown to
negatively effect the growth rate of their host cells as compared to untransfected
control cells. The production of a stable bioluminescent signal without a
corresponding reduction in cellular growth rate has confirmed our initial
hypothesis that continuous bioluminescent production is possible in the HEK293
cell line using codon-optimized lux gene sequences.

Hypothesis 2: Bioluminescent expression driven by codon-optimized
bacterial luciferase genes will allow improved temporal detection of signal
compared to bioluminescent signal from firefly luciferase and fluorescent
signal from green fluorescent protein in HEK293 cell culture and nude
mouse models.
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The bioluminescent signal resulting from expression of the mammalianadapted lux genes is stable over prolonged time periods as compared to that of
substrate dependent luciferase proteins and therefore allows for detection at
multiple time points throughout the life of the host cell. While multiple signal
detection is possible using repeated luciferin injections with alternative
bioluminescent systems, the lux system allows for increased resolution by
circumventing the requirement for luciferin clearance from the host prior to
secondary image acquisition. This allows investigators using the lux system to
achieve greater resolution of their visualized process by virtue of increasing the
total amount of images they can obtain within a given time period. In addition,
the substrate independent nature of the lux system provides investigators with a
larger window for imaging small animal hosts by freeing them from the
requirement of imaging at the same time point post substrate addition in order to
accurately compare data obtained from multiple time point studies. These major
considerations are all above and beyond the alleviation of standard concerns
related to the efficiency and consistency of substrate injection that must be
considered for any experiment utilizing conventional, exogenous luciferindependent bioluminescent systems.
While these concerns can also be avoided by imaging with a fluorescent
imaging target, the lux system has the advantage of producing a bioluminescent
signal with relatively low background in the mammalian cellular environment. As
such, the lux system has proven to require a lower reporter cell population in
order to successfully differentiate the signal from background light detection in
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both cell culture and small animal imaging conditions than its fluorescent
counterpart GFP. These combined advantages support our hypothesis that luxbased bioluminescent expression provides an improved system for temporal
detection of signal as compared to the Luc and GFP systems, however, this
statement must be considered in light of the relatively decreased bioluminescent
flux of the lux system in its current state. Both the Luc and GFP systems display
a greater photonic flux than does the lux system for an equal number of cells.
When imaging in the mammalian cellular environment, this is especially
important because the increased flux can overcome the negative effects of
scattering and absorption of detection signal photons due to endogenous
chromophoric material (Chance, Cope et al. 1998; Welsh and Kay 2005). For this
reason, the lux system may not always be an ideal choice of reporter for
mammalian imaging, especially if the detection signal is originating from depths
lower than a few millimeters of tissue. Under these conditions the advantages of
a higher flux system such as Luc may outweigh the disadvantages imposed by
its requirement for exogenous substrate addition. The choice of an appropriate
reporter system must therefore be made on a case-by-case basis at the
discretion of the investigator.

Hypothesis 3: By regulating the expression of the luxC and luxE genes
from the bacterial luciferase gene cassette it will be possible to construct a
bioluminescent reporter capable of responding to changes in target analyte
presence autonomously and in a near real-time manner.
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This investigation has demonstrated the proof-in-principle work showing
that regulation of the luxC and luxE genes under control of a tetracycline
response element is capable of regulating bioluminescent production in a doseresponse fashion, concurrent with administration of the activator chemical
doxycyline. Unfortunately, the results did not demonstrate a relatively large
increase in bioluminescent production in response to doxycyline treatment, nor
did they show induction of bioluminescent production across a wide range of
doxycycline concentrations. While the results obtained indicate that a
tetracycline receptor-based, luxC and luxE regulated biosensor is not yet ready
for routine laboratory use, they do show that regulating the production and
regeneration of the myristyl aldehyde substrate within the mammalian cellular
environment is a suitable method for controlling bioluminescent production from
the host cell. These results can serve as a springboard for future optimization
and design of lux-based bioreporters capable of responding to mammalian
bioavailable target analytes.

Hypothesis 4: HEK293 cells constitutively expressing bioluminescence
through expression of the codon-optimized bacterial luciferase genes will
be capable of acting as real-time biosensors to determine the mammalian
bioavailability of toxic chemicals.
Exposure of constitutively bioluminescent HEK293 cells to the cytotoxic
aldehyde n-decanal demonstrated a reduced level of bioluminescent production
from cells exposed to concentrations at or above 0.01% of the toxicant. This
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level of treatment is in line with previously published reports for aldehyde toxicity
(Rogers and McElroy 1958), supporting the hypothesis that continuously
bioluminescent cell lines can be developed into successful screening tools for
detection of mammalian bioavailable cytotoxic chemicals. The most important
finding from this line of inquiry is that fluctuations in bioluminescent production
can be detected during periods of transition from good to poor cellular health.
The ability to detect these transition periods is intrinsic to the autonomous nature
of the lux reaction. While it would be possible to visualize these fluctuations
using other bioluminescent reporter systems such as Luc, the costs and logistical
concerns related to the constant perfusion of luciferin would make these assays
unfeasible for both basic and high throughput screening applications.
Similarly, detection of these transition periods would prove problematic
using the commonly available fluorescent reporters, but for different reasons.
The short time period repeated imaging necessary to obtain the resolution
required for viewing small fluctuations in fluorescent production would entail
repeated administration of fluorescent excitation signals. If not provided with a
suitable recovery period between excitation signal applications, the fluorescent
reporter system could succumb to photobleaching, thereby rendering the results
suspect (Widengren and Rigler 1996).
In addition, both the fluorescent reporter proteins and the non-lux
bioluminescent reporter proteins derive their resulting photon production signal
from access to an exogenously supplied signal (either an excitation light signal
for fluorescent reporters, or a chemical luciferin addition for bioluminescent
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reporters). As a result, they would remain capable of producing an emission
signal regardless of changes in cellular health and metabolism, so long as the
reporter protein has not been degraded beyond use. This makes it challenging
to link changes in their resulting light expression signals to changes in cellular
health over relatively short time scales. Because the lux system is responsible
for continuously producing and regenerating its substrates using endogenously
available cellular materials it will be more adversely affected by changes in
cellular function than the alternative reporter systems would be over the same
time scale. This imparts a greater level of detection resolution to the lux system
than would be available for a similarly designed Luc or GFP-based system.
While additional work will be required before the mammalian-adapted lux system
can be employed for high throughput mammalian bioavailability toxicology
screening, the results demonstrated here suggest that it has excellent potential
for use in this field.
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